{"SLR NAME":"D-dimer levels on admission and in-hospital mortality risk of Covid-19 patients: A systematic review","References":[{"title1":"Clinical course and risk factors for mortality of adult inpatients with COVID-19 in Wuhan, China: a retrospective cohort study","References":[{"title2":"The novel coronavirus originating in Wuhan, China: challenges for global health governance","References":[]},{"title2":"Severe acute respiratory syndrome-related coronavirus: the species and its viruses:a statement of the Coronavirus Study Group","References":[]},{"title2":"Short term outcome and risk factors for adverse clinical outcomes in adults with severe acute respiratory syndrome (SARS)","References":[]},{"title2":"Early transmission dynamics in Wuhan, China, of novel coronavirus-infected pneumonia","References":[{"title3":"The 2019-nCoV Outbreak Joint Field Epidemiology Investigation Team, Li Q. Notes from the field: an outbreak of NCIP (2019-nCoV) infection in China : Wuhan, Hubei Province, 2019-2020."},{"title3":"A novel coronavirus genome identified in a cluster of pneumonia cases : Wuhan, China 2019-2020."},{"title3":"A novel coronavirus from patients with pneumonia in China, 2019."},{"title3":"Use of national pneumonia surveillance to describe influenza A(H7N9) virus epidemiology, China, 2004-2013."},{"title3":"A novel coronavirus emerging in China : key questions for impact assessment."},{"title3":"Evidence for camel-to-human transmission of MERS coronavirus."},{"title3":"Transmission dynamics and control of severe acute respiratory syndrome."},{"title3":"Dynamically modeling SARS and other newly emerging respiratory illnesses: past, present, and future."},{"title3":"Coronavirus infections : more than just the common cold."},{"title3":"Another decade, another coronavirus."},{"title3":"SARS and MERS: recent insights into emerging coronaviruses."},{"title3":"MERS, SARS, and Ebola: the role of super-spreaders in infectious disease."},{"title3":"A familial cluster of pneumonia associated with the 2019 novel coronavirus indicating person-to-person transmission: a study of a family cluster."},{"title3":"Real-time tentative assessment of the epidemiological characteristics of novel coronavirus infections in Wuhan, China, as at January 2020."},{"title3":"How to maintain surveillance for novel influenza A H1N1 when there are too many cases to count."}]},{"title2":"Clinical features of patients infected with 2019 novel coronavirus in Wuhan, China","References":[{"title3":"A familial cluster of pneumonia associated with the 2019 novel coronavirus indicating person-to-person transmission: a study of a family cluster"},{"title3":"A familial cluster of pneumonia associated with the 2019 novel coronavirus indicating person-to-person transmission: a study of a family cluster"},{"title3":"Epidemiological and clinical characteristics of 99 cases of 2019 novel coronavirus pneumonia in Wuhan, China: adescriptivestudy"},{"title3":"Epidemiological and clinical characteristics of 99 cases of 2019 novel coronavirus pneumonia in Wuhan, China: a descriptive study"},{"title3":"First case of 2019 novel coronavirus in the United States"},{"title3":"Clinical features of patients infected with 2019 novel coronavirus in Wuhan, China"},{"title3":"Lung CT image of a confirmed case of the 2019 novel coronavirus (2019-nCoV) infected pneumonia (With differential diagnosis of the SARS)"},{"title3":"Early transmission dynamics in Wuhan, China, of novel coronavirus-infected pneumonia"},{"title3":"Role of neutrophil to lymphocyte and monocyte to lymphocyte ratios in the diagnosis of bacterial infection in patients with fever"},{"title3":"Coronavirus infections-more than just the common cold"},{"title3":"The association between the neutrophil-to-lymphocyte ratio and mortality in critical illness: an observational cohort study"},{"title3":"A new coronavirus associated with human respiratory disease in China"},{"title3":"Monocyte/lymphocyte ratio as a better predictor of cardiovascular and all-cause mortality in hemodialysis patients: a prospective cohort study"},{"title3":"Ratio of neutrophil to lymphocyte counts-rapid and simple parameter of systemic inflammation and stress in critically ill"},{"title3":"Neutrophil-lymphocyte ratio as an early new marker in AIV-H7N9-infected patients: a retrospective study"}]},{"title2":"Clinical characteristics of 138 hospitalized patients with 2019 novel coronavirus-infected pneumonia in Wuhan, China","References":[]},{"title2":"Epidemiological and clinical characteristics of 99 cases of 2019 novel coronavirus pneumonia in Wuhan, China: a descriptive study","References":[{"title3":"Outbreak of pneumonia of unknown etiology in Wuhan China: the mystery and the miracle"},{"title3":"The continuing 2019-nCoV epidemic threat of novel coronaviruses to global health - the latest 2019 novel coronavirus outbreak in Wuhan, China"},{"title3":"Clinical features of patients infected with 2019 novel coronavirus in Wuhan, China"},{"title3":"Clinical management of severe acute respiratory infection when Novel coronavirus (nCoV) infection is suspected: interim guidance"},{"title3":"MERS, SARS and other coronaviruses as causes of pneumonia"},{"title3":"Identification of a novel coronavirus in patients with severe acute respiratory syndrome"},{"title3":"Isolation of a novel coronavirus from a man with pneumonia in Saudi Arabia"},{"title3":"Clinical features predicting mortality risk in patients with viral pneumonia: the MuLBSTA score"},{"title3":"Discovery of a rich gene pool of bat SARS-related coronaviruses provides new insights into the origin of SARS coronavirus"},{"title3":"Cross-host evolution of severe acute respiratory syndrome coronavirus in palm civet and human"},{"title3":"Middle East respiratory syndrome coronavirus in dromedary camels: an outbreak investigation"},{"title3":"Evidence for camel-to-human transmission of MERS coronavirus"},{"title3":"Surveillance of bat coronaviruses in Kenya identifies relatives of human coronaviruses NL63 and 229E and their recombination history"},{"title3":"Origin and evolution of pathogenic coronaviruses"},{"title3":"Fatal swine acute diarrhoea syndrome caused by an HKU2-related coronavirus of bat origin"},{"title3":"Evolution of the novel coronavirus from the ongoing Wuhan outbreak and modeling of its spike protein for the risk of human transmission"},{"title3":"Wuhan coronavirus has strong ability to infect humans. Press release"},{"title3":"From SARS to MERS, thrusting coronaviruses into the spotlight"},{"title3":"Prevalence of comorbidities in the Middle East respiratory syndrome coronavirus (MERS-CoV): a systematic review and meta-analysis"},{"title3":"Sex-based differences in susceptibility to severe acute respiratory syndrome coronavirus infection"},{"title3":"Sexual dimorphism in innate immunity"},{"title3":"Pathophysiology and burden of infection in patients with diabetes mellitus and peripheral vascular disease: focus on skin and soft-tissue infections"},{"title3":"Clinical findings in 111 cases of influenza A (H7N9) virus infection"},{"title3":"Clinical features of three avian influenza H7N9 virus-infected patients in Shanghai"},{"title3":"T-cell immunity of SARS-CoV: implications for vaccine development against MERS-CoV"}]},{"title2":"Management of adults with hospital-acquired and ventilator-associated pneumonia: 2016 clinical practice guidelines by the Infectious Diseases Society of America and the American Thoracic Society","References":[]},{"title2":"KDIGO clinical practice guidelines for acute kidney injury","References":[]},{"title2":"Acute respiratory distress syndrome: the Berlin Definition","References":[]},{"title2":"Chinese management guideline for COVID-19 (version 6.0)","References":[]},{"title2":"Clinical course and outcomes of critically ill patients with SARS-CoV-2 pneumonia in Wuhan, China: a single-centered, retrospective, observational study","References":[{"title3":"Clinical features of patients infected with 2019 novel coronavirus in Wuhan, China"},{"title3":"Epidemiological and clinical characteristics of 99 cases of 2019 novel coronavirus pneumonia in Wuhan, China: a descriptive study"},{"title3":"A novel coronavirus from patients with pneumonia in China, 2019"},{"title3":"First case of 2019 novel coronavirus in the United States"},{"title3":"Clinical characteristics of 138 hospitalized patients with 2019 novel coronavirus-infected pneumonia in Wuhan, China"},{"title3":"Clinical management of severe acute respiratory infection when novel coronavirus (nCoV) infection is suspected"},{"title3":"Critically ill patients with 2009 influenza A(H1N1) in Mexico"},{"title3":"Critically ill patients with severe acute respiratory syndrome"},{"title3":"Critically ill patients with 2009 influenza A(H1N1) infection in Canada"},{"title3":"KDIGO clinical practice guideline for acute kidney injury"},{"title3":"Wuhan: Britons to be evacuated as scientists estimate 44 000 cases of 2019-nCOV in the city"},{"title3":"Acute respiratory distress syndrome in critically ill patients with severe acute respiratory syndrome"},{"title3":"Short-term outcome of critically ill patients with severe acute respiratory syndrome"},{"title3":"Clinical course and outcomes of critically ill patients with Middle East respiratory syndrome coronavirus infection"},{"title3":"SARS and MERS: recent insights into emerging coronaviruses"},{"title3":"Epidemiology, patterns of care, and mortality for patients with acute respiratory distress syndrome in intensive care units in 50 countries"},{"title3":"China built a hospital in 10 days to battle coronavirus"},{"title3":"Transmission of 2019-nCoV infection from an asymptomatic contact in Germany"},{"title3":"Asymptomatic cases complicate efforts"},{"title3":"Multiple organ infection and the pathogenesis of SARS"},{"title3":"Middle East respiratory syndrome coronavirus efficiently infects human primary T lymphocytes and activates the extrinsic and intrinsic apoptosis pathways"},{"title3":"T-cell immunity of SARS-CoV: implications for vaccine development against MERS-CoV"},{"title3":"Practice of diagnosis and management of acute respiratory distress syndrome in mainland China: a cross-sectional study"},{"title3":"Clinical evidence does not support corticosteroid treatment for 2019-nCoV lung injury"}]},{"title2":"Middle East respiratory syndrome","References":[]},{"title2":"Outcomes and prognostic factors in 267 patients with severe acute respiratory syndrome in Hong Kong","References":[]},{"title2":"Predictors of mortality in Middle East respiratory syndrome (MERS)","References":[{"title3":"Middle East Respiratory Syndrome-Coronavirus (MERS-CoV): a case-controlstudy of hospitalized patients"},{"title3":"Predictors of MERS-CoV infection: a large case control study of patients presenting with ILI at a MERS-CoV referral hospital in Saudi Arabia"},{"title3":"A comparative study of clinical presentation and risk factors for adverse outcome in patients hospitalised with acute respiratory disease due to MERS coronavirus or other causes"},{"title3":"Differential Cell count and CRP level in Blood as predictors for Middle East respiratory syndrome coronavirus infection in acute febrile patients during nosocomial outbreak"},{"title3":"Managing MERS-CoV in the healthcare setting"},{"title3":"Hospital outbreak of Middle East respiratory syndrome coronavirus"},{"title3":"Epidemiological, demographic, and clinical characteristics of 47 cases of Middle East respiratory syndrome coronavirus disease from Saudi Arabia: a descriptive study"},{"title3":"High fatality rates and associated factors in two hospital outbreaks of MERS in Daejeon, the Republic of Korea"},{"title3":"A cohort-study of patients suspected for MERS-CoV in a referral hospital in Saudi Arabia"},{"title3":"Middle East respiratory syndrome coronavirus (MERS-CoV) outbreak in South Korea, 2015: epidemiology, characteristics and public health implications"},{"title3":"Clinical presentation and outcomes of Middle East respiratory syndrome in the Republic of Korea"},{"title3":"Clinical aspects and outcomes of 70 patients with Middle East respiratory syndrome coronavirus infection: a single-center experience in Saudi Arabia"},{"title3":"Imported cases of Middle East respiratory syndrome: an update"},{"title3":"Travel implications of emerging coronaviruses: SARS and MERS-CoV"},{"title3":"The characteristics of Middle eastern respiratory syndrome coronavirus transmission dynamics in South Korea"},{"title3":"Middle East respiratory syndrome coronavirus outbreak in the Republic of Korea"},{"title3":"Middle East respiratory syndrome coronavirus (MERS-CoV): prevention in travelers"},{"title3":"Systematic review of emerging respiratory viruses at the Hajj and possible coinfection with Streptococcus pneumoniae"},{"title3":"Asymptomatic Middle East Respiratory Syndrome Coronavirus (MERS-CoV) infection: extent and implications for infection control: a systematic review"},{"title3":"Epidemiology and predictors of survival of MERS-CoV infections in Riyadh region, 2014-2015"},{"title3":"Assays for laboratory confirmation of novel human coronavirus (hCoV-EMC) infections"},{"title3":"Influenza is more common than Middle East Respiratory Syndrome Coronavirus (MERS-CoV) among hospitalized adult Saudi patients"},{"title3":"Drivers of MERS-CoV transmission: what do we know?"},{"title3":"Middle East respiratory syndrome coronavirus: epidemiology and disease control measures"},{"title3":"Taking stock of the first 133 mers coronavirus cases globally-is the epidemic changing?"},{"title3":"State of knowledge and data gaps of Middle East respiratory syndrome coronavirus (MERS-CoV) in humans"},{"title3":"The predictors of 3- and 30-day mortality in 660 MERS-CoV patients"},{"title3":"Corticosteroid therapy for critically ill patients with Middle East respiratory syndrome"},{"title3":"Clinical aspects and outcomes of 70 patients with Middle East respiratory syndrome coronavirus infection: a single-center experience in Saudi Arabia"},{"title3":"Renal complications and their prognosis in Korean patients with Middle East respiratory syndrome-coronavirus from the central MERS-cov designated hospital"},{"title3":"Critically ill patients with the Middle East respiratory syndrome"},{"title3":"Extracorporeal membrane oxygenation for severe Middle East respiratory syndrome coronavirus"}]},{"title2":"Exacerbated innate host response to SARS-CoV in aged non-human primates","References":[{"title3":"Innate immunity and inflammation in ageing: a key for understanding age-related diseases."},{"title3":"Aging."},{"title3":"Aging and innate immune cells."},{"title3":"The role of immunity in susceptibility to respiratory infection in the aging lung."},{"title3":"Clinical progression and viral load in a community outbreak of coronavirus-associated SARS pneumonia: a prospective study."},{"title3":"Severe acute respiratory syndrome."},{"title3":"An interferon-gamma-related cytokine storm in SARS patients."},{"title3":"Characterization of cytokine/chemokine profiles of severe acute respiratory syndrome."},{"title3":"The acute respiratory distress syndrome."},{"title3":"Clinical presentations and outcome of severe acute respiratory syndrome in children."},{"title3":"Clinical picture, diagnosis, treatment and outcome of severe acute respiratory syndrome (SARS) in children."},{"title3":"Severe acute respiratory syndrome in children."},{"title3":"Interferon-mediated immunopathological events are associated with atypical innate and adaptive immune responses in patients with severe acute respiratory syndrome."},{"title3":"Participation of both host and virus factors in induction of severe acute respiratory syndrome (SARS) in F344 rats infected with SARS coronavirus."},{"title3":"Early enhanced expression of interferon-inducible protein-10 (CXCL-10) and other chemokines predicts adverse outcome in severe acute respiratory syndrome."},{"title3":"Plasma inflammatory cytokines and chemokines in severe acute respiratory syndrome."},{"title3":"Cytokine responses in severe acute respiratory syndrome coronavirus-infected macrophages in vitro: possible relevance to pathogenesis."},{"title3":"Chemokine up-regulation in SARS-coronavirus-infected, monocyte-derived human dendritic cells."},{"title3":"Functional genomics highlights differential induction of antiviral pathways in the lungs of SARS-CoV-infected macaques."},{"title3":"Prognostic determinants of acute respiratory distress syndrome in adults: impact on clinical trial design."},{"title3":"Aetiology: Koch's postulates fulfilled for SARS virus."},{"title3":"Pegylated interferon-alpha protects type 1 pneumocytes against SARS coronavirus infection in macaques."},{"title3":"Newly discovered coronavirus as the primary cause of severe acute respiratory syndrome."},{"title3":"Transcriptional mechanisms of acute lung injury."},{"title3":"Identification of oxidative stress and Toll-like receptor 4 signaling as a key pathway of acute lung injury."},{"title3":"A global test for groups of genes: testing association with a clinical outcome."},{"title3":"Acid aspiration-induced lung injury in rabbits is mediated by interleukin-8-dependent mechanisms."},{"title3":"Acid-induced lung injury. Protective effect of anti-interleukin-8 pretreatment on alveolar epithelial barrier function in rabbits."},{"title3":"Unbiased reconstruction of a mammalian transcriptional network mediating pathogen responses."},{"title3":"Acetylation of Stat1 modulates NF-kappaB activity."},{"title3":"Pathogen recognition and innate immunity."},{"title3":"The interleukin 1 receptor: ligand interactions and signal transduction."},{"title3":"Nonhuman primate models for SARS."},{"title3":"The molecular inflammatory process in aging."},{"title3":"Regulation of neutral sphingomyelinase-2 by GSH: a new insight to the role of oxidative stress in aging-associated inflammation."},{"title3":"IL-1R1/MyD88 signaling and the inflammasome are essential in pulmonary inflammation and fibrosis in mice."},{"title3":"Immunosenescence: emerging challenges for an ageing population."},{"title3":"Aging and proinflammatory cytokines."},{"title3":"Inflamm-aging. An evolutionary perspective on immunosenescence."},{"title3":"The membrane protein of SARS-CoV suppresses NF-kappaB activation."},{"title3":"SARS coronavirus and innate immunity."},{"title3":"Severe acute respiratory syndrome coronavirus open reading frame (ORF) 3b, ORF 6, and nucleocapsid proteins function as interferon antagonists."},{"title3":"Genomic Analysis Reveals Age Dependent Innate Immune Responses to SARS Coronavirus."},{"title3":"Early upregulation of acute respiratory distress syndrome-associated cytokines promotes lethal disease in an aged-mouse model of severe acute respiratory syndrome coronavirus infection."},{"title3":"Control of coronavirus infection through plasmacytoid dendritic-cell-derived type I interferon."},{"title3":"Dysregulation of TLR3 impairs the innate immune response to West Nile virus in the elderly."},{"title3":"Altered cytokine production in the elderly."},{"title3":"Macrophage hypo-responsiveness to interferon-gamma in aged mice is associated with impaired signaling through Jak-STAT."},{"title3":"Distinct and nonredundant in vivo functions of IFNAR on myeloid cells limit autoimmunity in the central nervous system."},{"title3":"Suppression of experimental allergic encephalomyelitis by interferon."},{"title3":"Anti-inflammatory properties of Type I interferons."},{"title3":"The type I IFN induction pathway constrains Th17-mediated autoimmune inflammation in mice."},{"title3":"Treatment with recombinant interferon-beta reduces inflammation and slows cartilage destruction in the collagen-induced arthritis model of rheumatoid arthritis."},{"title3":"Mechanism of IFN-beta-mediated inhibition of IL-8 gene expression in astroglioma cells."},{"title3":"When signaling pathways collide: positive and negative regulation of toll-like receptor signal transduction."},{"title3":"TAM receptors are pleiotropic inhibitors of the innate immune response."},{"title3":"Interferon-alpha stimulates production of interleukin-10 in activated CD4+ T cells and monocytes."},{"title3":"Differential effects of TNF-alpha and IFN-gamma on gene transcription mediated by NF-kappaB-Stat1 interactions."},{"title3":"Influenza A virus inhibits type I IFN signaling via NF-kappaB-dependent induction of SOCS-3 expression."},{"title3":"NFkappaB negatively regulates interferon-induced gene expression and anti-influenza activity."},{"title3":"Mouse-passaged severe acute respiratory syndrome-associated coronavirus leads to lethal pulmonary edema and diffuse alveolar damage in adult but not young mice."},{"title3":"Interferon alfacon-1 plus corticosteroids in severe acute respiratory syndrome: a preliminary study."},{"title3":"Analysis of relative gene expression data using real-time quantitative PCR and the 2(-Delta Delta C(T)) Method."},{"title3":"Variance stabilization applied to microarray data calibration and to the quantification of differential expression."},{"title3":"Some thoughts on clinical trials, especially problems of multiplicity."},{"title3":"Linear models and empirical bayes methods for assessing differential expression in microarray experiments."},{"title3":"Controlling the false discovery rate: a practical and powerful approach to multiple testing."}]},{"title2":"The immunopathogenesis of sepsis in elderly patients","References":[]},{"title2":"The Third International Consensus Definitions for Sepsis and Septic Shock (Sepsis-3)","References":[{"title3":"The role of glucocorticoids as adjunctive treatment for sepsis in the modern era"},{"title3":"Corticosteroids for treating sepsis"},{"title3":"Corticosteroids for severe sepsis and septic shock: a systematic review and meta-analysis"},{"title3":"Association of corticosteroid treatment with outcomes in adult patients with sepsis: a systematic review and meta-analysis"},{"title3":"Reevaluating the role of corticosteroids in septic shock: an updated meta-analysis of randomized controlled trials"},{"title3":"Can corticosteroids reduce the mortality of patients with severe sepsis? A systematic review and meta-analysis"},{"title3":"Corticosteroid treatment for sepsis: a critical appraisal and meta-analysis of the literature"},{"title3":"Corticosteroids in sepsis: an updated systematic review and meta-analysis"},{"title3":"Effect of adjunctive corticosteroids on clinical outcomes in adult patients with septic shock-a meta-analysis of randomized controlled trials and trial sequential analysis"},{"title3":"Low-dose corticosteroids for adult patients with septic shock: a systematic review with meta-analysis and trial sequential analysis"},{"title3":"Adjunctive glucocorticoid therapy in patients with septic shock"},{"title3":"Hydrocortisone plus fludrocortisone for adults with septic shock"},{"title3":"2001 sccm/esicm/accp/ats/sis international sepsis definitions conference"},{"title3":"Definitions for sepsis and organ failure and guidelines for the use of innovative therapies in sepsis"},{"title3":"Sepsis definitions: time for change"},{"title3":"The third international consensus definitions for sepsis and septic shock (Sepsis-3)"},{"title3":"Use of the SOFA score to assess the incidence of organ dysfunction/failure in intensive care units: results of a multicenter, prospective study"},{"title3":"Hydrocortisone Compared with Placebo in Patients with Septic Shock Satisfying the Sepsis-3 Diagnostic Criteria and APROCCHSS Study Inclusion CriteriaA Post Hoc Analysis of the ADRENAL Trial"},{"title3":"The reporting of studies conducted using observational routinely collected health data statement for pharmacoepidemiology (RECORD-PE)"},{"title3":"Using big data to emulate a target trial when a randomized trial is not available"},{"title3":"The eICU Collaborative Research Database, a freely available multi-center database for critical care research"},{"title3":"Identifying patients with severe sepsis using administrative claims: patient-level validation of the angus implementation of the international consensus conference definition of severe sepsis"},{"title3":"FDA-Approved Drugs: SOLU-MEDROL U.S. FOOD &amp; DRUG Web site. Accessed 18 April 2020 https://www.accessdata.fda.gov/scripts/cder/daf/index.cfm?event=BasicSearch.process"},{"title3":"FDA-Approved Drugs: SOLU-CORTEF U.S. FOOD &amp; DRUG Web site. Accessed 18 April 2020 https://www.accessdata.fda.gov/scripts/cder/daf/index.cfm?event=overview.process&amp;ApplNo=009866"},{"title3":"Early initiation of low-dose hydrocortisone treatment for septic shock in adults: a randomized clinical trial"},{"title3":"Reversal of late septic shock with supraphysiologic doses of hydrocortisone"},{"title3":"Immortal time bias in pharmacoepidemiology"},{"title3":"Low-dose hydrocortisone in patients with cirrhosis and septic shock: a randomized controlled trial"},{"title3":"Value of glucocorticoid steroids in the treatment of patients with severe community-acquired pneumonia complicated with septic shock"},{"title3":"Hydrocortisone therapy for patients with septic shock"},{"title3":"National analysis of sepsis hospitalizations and factors contributing to sepsis in-hospital mortality in Canada"},{"title3":"Glucose variability and mortality in patients with sepsis"},{"title3":"Prognostic factors of mortality in patients with community-acquired bloodstream infection with severe sepsis and septic shock"},{"title3":"The effect of comorbidity and age on hospital mortality and length of stay in patients with sepsis"},{"title3":"Adjusted survival curves with inverse probability weights"},{"title3":"Balance diagnostics for comparing the distribution of baseline covariates between treatment groups in propensity-score matched samples"},{"title3":"Moving towards best practice when using inverse probability of treatment weighting (IPTW) using the propensity score to estimate causal treatment effects in observational studies"},{"title3":"Variance estimation when using inverse probability of treatment weighting (IPTW) with survival analysis"},{"title3":"The interaction of vasopressin and corticosteroids in septic shock: a pilot randomized controlled trial"},{"title3":"Effect of treatment with low doses of hydrocortisone and fludrocortisone on mortality in patients with septic shock"},{"title3":"Effect of hydrocortisone on development of shock among patients with severe sepsis: the HYPRESS randomized clinical trial"},{"title3":"Effect of early vasopressin vs norepinephrine on kidney failure in patients with septic shock: the VANISH randomized clinical trial"},{"title3":"Dexamethasone and length of hospital stay in patients with community-acquired pneumonia: a randomised, double-blind, placebo-controlled trial"},{"title3":"The effects of high-dose corticosteroids in patients with septic shock: a prospective, controlled study"},{"title3":"Ineffectiveness of high-dose methylprednisolone in preventing parenchymal lung injury and improving mortality in patients with septic shock"},{"title3":"Corticosteroids for treating sepsis in children and adults"},{"title3":"Steroids in the treatment of clinical septic shock"},{"title3":"Sepsis, severe sepsis and septic shock: changes in incidence, pathogens and outcomes"},{"title3":"Effect of corticosteroids on treatment failure among hospitalized patients with severe community-acquired pneumonia and high inflammatory response: a randomized clinical trial"},{"title3":"Reduced cortisol metabolism during critical illness"},{"title3":"Cortisol levels and mortality in severe sepsis"},{"title3":"Why Test for Proportional Hazards?"},{"title3":"Surviving sepsis campaign: international guidelines for management of sepsis and septic shock: 2016"},{"title3":"Problem of immortal time bias in cohort studies: example using statins for preventing progression of diabetes"}]},{"title2":"Serial evaluation of the SOFA score to predict outcome in critically ill patients","References":[]},{"title2":"Disease severity and clinical outcomes of community-acquired pneumonia caused by non-influenza respiratory viruses in adults: a multicentre prospective registry study from the CAP-China Network","References":[]},{"title2":"Community-acquired pneumonia requiring admission to an intensive care unit: a descriptive study","References":[]},{"title2":"Acute pneumonia and the cardiovascular system","References":[]},{"title2":"Association between influenza vaccination and cardiovascular outcomes in high-risk patients: a meta-analysis","References":[]},{"title2":"Laboratory-confirmed respiratory infections as predictors of hospital admission for myocardial infarction and stroke: time-series analysis of English data for 2004-2015","References":[{"title3":"Global, regional, and national life expectancy, all-cause mortality, and cause-specific mortality for 249 causes of death, 1980-2015: a systematic analysis for the Global Burden of Disease Study 2015"},{"title3":"Mortality from cardiovascular and cerebrovascular diseases in Europe and other areas of the world: an update"},{"title3":"Risk of myocardial infarction and stroke after acute infection or vaccination"},{"title3":"Recent respiratory infection and risk of cardiovascular disease: case-control study through a general practice database"},{"title3":"Influenza infection and risk of acute myocardial infarction in England and Wales: a CALIBER self-controlled case series study"},{"title3":"Association between influenza vaccination and cardiovascular outcomes in high-risk patients: a meta-analysis"},{"title3":"The art of modeling the mortality impact of winter-seasonal pathogens"},{"title3":"Seasonal influenza infections and cardiovascular disease mortality"},{"title3":"Influenza associated mortality in the subtropics and tropics: results from three Asian cities"},{"title3":"Circulating influenza virus, climatic factors, and acute myocardial infarction: a time series study in England and Wales and Hong Kong"},{"title3":"Mortality caused by influenza and respiratory syncytial virus by age group in England and Wales 1999-2010"},{"title3":"Mortality attributable to influenza in England and Wales prior to, during and after the 2009 pandemic"},{"title3":"Mortality attributable to 9 common infections: significant effect of influenza A, respiratory syncytial virus, influenza B, norovirus, and parainfluenza in elderly persons"},{"title3":"Global burden of influenza as a cause of cardiopulmonary morbidity and mortality"},{"title3":"Surveillance of antibiotic resistance"},{"title3":"The computation of equivalent potential temperature"},{"title3":"Third universal definition of myocardial infarction"},{"title3":"Influenza as a trigger for acute myocardial infarction or death from cardiovascular disease: a systematic review"},{"title3":"Triggering of acute myocardial infarction by respiratory infection"},{"title3":"Acute cardiac injury events &lt;/=30 days after laboratory-confirmed influenza virus infection among U.S. veterans, 2010-2012"},{"title3":"Influenza and coronary artery disease: exploring a clinical association with myocardial infarction and analyzing the utility of vaccination in prevention of myocardial infarction"},{"title3":"Influenza, influenza-like symptoms and their association with cardiovascular risks: a systematic review and meta-analysis of observational studies"},{"title3":"Influenza vaccine as a coronary intervention for prevention of myocardial infarction"},{"title3":"Influenza vaccines for preventing cardiovascular disease"},{"title3":"A matched influenza vaccine strain was effective in reducing the risk of acute myocardial infarction in elderly persons: a population-based study"},{"title3":"Acute myocardial infarctions, strokes and influenza: seasonal and pandemic effects"},{"title3":"The causes and diagnosis of influenza-like illness"},{"title3":"Epidemiology of parainfluenza infection in England and Wales, 1998-2013: any evidence of change"},{"title3":"Relationship between supra-annual trends in influenza rates and stroke occurrence"},{"title3":"Role of acute infection in triggering acute coronary syndromes"},{"title3":"Complications and outcomes of pandemic 2009 influenza A (H1N1) virus infection in hospitalized adults: how do they differ from those in seasonal influenza"},{"title3":"Clinical aspects of pandemic 2009 influenza A (H1N1) virus infection"},{"title3":"Influenza vaccination is associated with a reduced risk of stroke"},{"title3":"Influenza vaccination reduces hemorrhagic stroke risk in patients with atrial fibrillation: a population-based cohort study"},{"title3":"Influenza vaccination and cardiovascular risk in patients with recent TIA and stroke"},{"title3":"Comparison of two rapid influenza A/B test kits with reference methods showing high specificity and sensitivity for influenza A infection"},{"title3":"Model selection in time series studies of influenza-associated mortality"},{"title3":"Cardiac complications in patients with community-acquired pneumonia: a systematic review and meta-analysis of observational studies"},{"title3":"Neuraminidase inhibitors for preventing and treating influenza in healthy adults and children"},{"title3":"Cardiovascular disease as a complication of community-acquired pneumonia"},{"title3":"Rationale and design of a randomized controlled trial of pneumococcal polysaccharide vaccine for prevention of cardiovascular events: the Australian Study for the Prevention through Immunization of Cardiovascular Events (AUSPICE)"},{"title3":"Association between pneumococcal vaccination and cardiovascular outcomes: a systematic review and meta-analysis of cohort studies"}]},{"title2":"Prevalence and significance of coagulation abnormalities in community-acquired pneumonia","References":[]},{"title2":"D-dimer is a significant prognostic factor in patients with suspected infection and sepsis","References":[]},{"title2":"Risk of myocardial infarction and stroke after acute infection or vaccination","References":[]},{"title2":"Cardiac complications in patients with community-acquired pneumonia: incidence, timing, risk factors, and association with short-term mortality","References":[]},{"title2":"Cardiovascular complications of acute respiratory infections: current research and future directions","References":[]},{"title2":"Regulation of ACE2 in cardiac myocytes and fibroblasts","References":[]},{"title2":"ACE2 and vasoactive peptides: novel players in cardiovascular/renal remodeling and hypertension","References":[]},{"title2":"Pathological findings of COVID-19 associated with acute respiratory distress syndrome","References":[{"title3":"A new coronavirus associated with human respiratory disease in China"},{"title3":"Clinical features of patients infected with 2019 novel coronavirus in Wuhan, China"},{"title3":"A familial cluster of pneumonia associated with the 2019 novel coronavirus indicating person-to-person transmission: a study of a family cluster"},{"title3":"The clinical pathology of severe acute respiratory syndrome (SARS): a report from China"},{"title3":"Clinicopathologic, immunohistochemical, and ultrastructural findings of a fatal case of Middle East respiratory syndrome coronavirus infection in the United Arab Emirates, April 2014"}]},{"title2":"Persistent shedding of viable SARS-CoV in urine and stool of SARS patients during the convalescent phase","References":[{"title3":"World Health Organization (2004) Summary of probable SARS with onset of illness from 1 November 2002 to 31 July 2003. Available at: http://www.who.int/csr/sars/country/table2004_04_21/en/. Cited 8 May 2004"},{"title3":"SARS: responding to an unknown virus"},{"title3":"Identification of a novel coronavirus in patients with severe acute respiratory syndrome"},{"title3":"A novel coronavirus associated with severe acute respiratory syndrome"},{"title3":"The genome sequence of the SARS-associated coronavirus"},{"title3":"Coronavirus as a possible cause of severe acute respiratory syndrome"},{"title3":"Characterization of a novel coronavirus associated with severe acute respiratory syndrome"},{"title3":"Aetiology: Koch's postulates fulfilled for SARS virus"},{"title3":"Clinical progression and viral load in a community outbreak of coronavirus-associated SARS pneumonia: a prospective study"},{"title3":"Profile of specific antibodies to the SARS-associated coronavirus"},{"title3":"Serology of severe acute respiratory syndrome: implications for surveillance and outcome"},{"title3":"SARS-CoV antibody prevalence in all Hong Kong patient contacts"},{"title3":"Early diagnosis of SARS coronavirus infection by real time RT-PCR"},{"title3":"Detection of SARS coronavirus in patients with severe acute respiratory syndrome by conventional and real-time quantitative reverse transcription-PCR assays"},{"title3":"Detection of SARS coronavirus in patients with suspected SARS"},{"title3":"Preclinical evaluation of two real-time, reverse transcription-PCR assays for detection of the severe acute respiratory syndrome coronavirus"},{"title3":"World Health Organization (2003) PCR primers for SARS developed by WHO network laboratories [monograph on the Internet]. Available at: http://www.who.int/csr/sars/primers/en/. Cited 20 April 2003"},{"title3":"Epidemiological features of severe acute respiratory syndrome in Beijing"},{"title3":"Epidemiologic features, clinical diagnosis and therapy of first cluster of patients with severe acute respiratory syndrome in Beijing area"},{"title3":"Severe acute respiratory syndrome (SARS)-paradigm of an emerging viral infection"},{"title3":"Performance and cost evaluation of one commercial and six in-house conventional and real-time reverse transcription-PCR assays for detection of severe acute respiratory syndrome coronavirus"},{"title3":"Genetic variation of SARS coronavirus in Beijing hospital"},{"title3":"Clinical analysis of pediatric SARS cases in Beijing"},{"title3":"Virus-specific RNA and antibody from convalescent-phase SARS patients discharged from hospital"},{"title3":"Microbiologic characteristics, serologic responses, and clinical manifestations in severe acute respiratory syndrome, Taiwan"},{"title3":"SARS-associated coronavirus quasispeies in individual patients"},{"title3":"Isolation and identification of SARS-CoV from stool of SARS patients in different phase of disease"}]},{"title2":"Viral shedding and antibody response in 37 patients with Middle East Respiratory Syndrome coronavirus infection","References":[]},{"title2":"Viral load kinetics of MERS coronavirus infection","References":[]},{"title2":"Factors associated with prolonged viral shedding in patients with avian influenza A(H7N9) virus infection","References":[{"title3":"Human infection with a novel avian-origin influenza A (H7N9) virus"},{"title3":"Epidemiology of avian influenza A H7N9 virus in human beings across five epidemics in mainland China, 2013-17: an epidemiological study of laboratory-confirmed case series"},{"title3":"Sudden increase in human infection with avian influenza A(H7N9) virus in China, September-December 2016"},{"title3":"Update: increase in human infections with novel Asian lineage avian influenza A(H7N9) viruses during the fifth epidemic - China, October 1, 2016-August 7, 2017"},{"title3":"Epidemiology of human infections with highly pathogenic avian influenza A(H7N9) virus in Guangdong, 2016 to 2017"},{"title3":"Preliminary epidemiology of human infections with highly pathogenic avian influenza A(H7N9) virus, China, 2017"},{"title3":"Novel influenza A viruses and pandemic threats"},{"title3":"Pathogenesis of influenza-induced acute respiratory distress syndrome"},{"title3":"Influenza virus-induced lung injury: pathogenesis and implications for treatment"},{"title3":"Viral loads and duration of viral shedding in adult patients hospitalized with influenza"},{"title3":"Antiviral therapy and outcomes of influenza requiring hospitalization in Ontario, Canada"},{"title3":"Outcomes from pandemic influenza A H1N1 infection in recipients of solid-organ transplants: a multicentre cohort study"},{"title3":"Effectiveness of oseltamivir on disease progression and viral RNA shedding in patients with mild pandemic 2009 influenza A H1N1: opportunistic retrospective study of medical charts in China"},{"title3":"Treatment with neuraminidase inhibitors for critically ill patients with influenza A (H1N1)pdm09"},{"title3":"Impact of neuraminidase inhibitor treatment on outcomes of public health importance during the 2009-2010 influenza A(H1N1) pandemic: a systematic review and meta-analysis in hospitalized patients"},{"title3":"Effectiveness of neuraminidase inhibitors in reducing mortality in patients admitted to hospital with influenza A H1N1pdm09 virus infection: a meta-analysis of individual participant data"},{"title3":"Determinants of antiviral effectiveness in influenza virus A subtype H5N1"},{"title3":"Systematic review of influenza A(H1N1)pdm09 virus shedding: duration is affected by severity, but not age"},{"title3":"Benefit of early initiation of neuraminidase inhibitor treatment to hospitalized patients with avian influenza A (H7N9) virus"},{"title3":"Adjuvant Corticosteroid Treatment in Adults With Influenza A (H7N9) Viral Pneumonia"},{"title3":"Clinical findings in 111 cases of influenza A (H7N9) virus infection"},{"title3":"Use of corticosteroids in acute lung injury and acute respiratory distress syndrome: a systematic review and meta-analysis"},{"title3":"Corticosteroid therapy for critically ill patients with the middle east respiratory syndrome"},{"title3":"Fatal outcome of human influenza A (H5N1) is associated with high viral load and hypercytokinemia"},{"title3":"H5N1 infection of the respiratory tract and beyond: a molecular pathology study"},{"title3":"The role of adjuvant immunomodulatory agents for treatment of severe influenza"},{"title3":"Effects of early corticosteroid treatment on plasma SARS-associated Coronavirus RNA concentrations in adult patients"},{"title3":"Association between adverse clinical outcome in human disease caused by novel influenza A H7N9 virus and sustained viral shedding and emergence of antiviral resistance"},{"title3":"Human infection with highly pathogenic avian influenza A(H7N9) virus, China"},{"title3":"Efficacy of oseltamivir-zanamivir combination compared to each monotherapy for seasonal influenza: a randomized placebo-controlled trial"},{"title3":"Effect of double dose oseltamivir on clinical and virological outcomes in children and adults admitted to hospital with severe influenza: double blind randomised controlled trial"},{"title3":"Effectiveness of antiviral treatment in human influenza A(H5N1) infections: analysis of a Global Patient Registry"},{"title3":"Antiviral therapy and outcomes of patients with pneumonia caused by influenza A pandemic (H1N1) virus"},{"title3":"A prospective intervention study on higher-dose oseltamivir treatment in adults hospitalized with influenza a and B infections"},{"title3":"Oseltamivir in seasonal, avian H5N1 and pandemic 2009 A/H1N1 influenza: pharmacokinetic and pharmacodynamic characteristics"},{"title3":"Comparison of the anti-influenza virus activity of RWJ-270201 with those of oseltamivir and zanamivir"},{"title3":"Pharmacokinetics of oseltamivir: an oral antiviral for the treatment and prophylaxis of influenza in diverse populations"},{"title3":"Efficacy of oseltamivir-peramivir combination therapy compared to oseltamivir monotherapy for Influenza A (H7N9) infection: a retrospective study"},{"title3":"Antiviral combinations for severe influenza"}]},{"title2":"SARS-CoV-2 viral load in upper respiratory specimens of infected patients","References":[{"title3":"Summary of probable SARS cases with onset of illness from 1 November 2002 to 31 July 2003. Geneva: World Health Organization, 2004 ()."},{"title3":"Transmission dynamics and control of severe acute respiratory syndrome."},{"title3":"Clinical progression and viral load in a community outbreak of coronavirus-associated SARS pneumonia: a prospective study."},{"title3":"Influenza A virus shedding and infectivity in households."},{"title3":"Transmission of 2019-nCoV infection from an asymptomatic contact in Germany."}]}]},{"title1":"D?dimer levels on admission to predict in?hospital mortality in patients with Covid?19","References":[{"title2":"Clinical features of patients infected with 2019 novel coronavirus in Wuhan, China","References":[{"title3":"A familial cluster of pneumonia associated with the 2019 novel coronavirus indicating person-to-person transmission: a study of a family cluster"},{"title3":"A familial cluster of pneumonia associated with the 2019 novel coronavirus indicating person-to-person transmission: a study of a family cluster"},{"title3":"Epidemiological and clinical characteristics of 99 cases of 2019 novel coronavirus pneumonia in Wuhan, China: adescriptivestudy"},{"title3":"Epidemiological and clinical characteristics of 99 cases of 2019 novel coronavirus pneumonia in Wuhan, China: a descriptive study"},{"title3":"First case of 2019 novel coronavirus in the United States"},{"title3":"Clinical features of patients infected with 2019 novel coronavirus in Wuhan, China"},{"title3":"Lung CT image of a confirmed case of the 2019 novel coronavirus (2019-nCoV) infected pneumonia (With differential diagnosis of the SARS)"},{"title3":"Early transmission dynamics in Wuhan, China, of novel coronavirus-infected pneumonia"},{"title3":"Role of neutrophil to lymphocyte and monocyte to lymphocyte ratios in the diagnosis of bacterial infection in patients with fever"},{"title3":"Coronavirus infections-more than just the common cold"},{"title3":"The association between the neutrophil-to-lymphocyte ratio and mortality in critical illness: an observational cohort study"},{"title3":"A new coronavirus associated with human respiratory disease in China"},{"title3":"Monocyte/lymphocyte ratio as a better predictor of cardiovascular and all-cause mortality in hemodialysis patients: a prospective cohort study"},{"title3":"Ratio of neutrophil to lymphocyte counts-rapid and simple parameter of systemic inflammation and stress in critically ill"},{"title3":"Neutrophil-lymphocyte ratio as an early new marker in AIV-H7N9-infected patients: a retrospective study"}]},{"title2":"Clinical characteristics of 138 hospitalized patients with 2019 novel coronavirus-infected pneumonia in Wuhan, China","References":[]},{"title2":"Coronavirus disease (COVID-19) Pandemic.2020. https://www.who.int/emergencies/diseases/novel-coronavirus-2019.","References":[]},{"title2":"Johns Hopkins University CSSE. The novel coronavirus (2019-nCoV) global cases 2020. https://gisanddata.maps.arcgis.com/apps/opsdashboard/index.html#/bda7594740fd40299423467b48e9ecf6. (Accessed March 31, 2020). https://gisanddata.maps.arcgis.com/apps/opsdashboard/index.html#/bda7594740fd40299423467b48e9ecf6.","References":[]},{"title2":"China Medical Treatment Expert Group for C. Clinical characteristics of coronavirus disease 2019 in China","References":[]},{"title2":"ISTH interim guidance on recognition and management of coagulopathy in COVID-19","References":[{"title3":"Clinical features of patients infected with 2019 novel coronavirus in Wuhan, China"},{"title3":"Clinical Characteristics of Coronavirus Disease 2019 in China"},{"title3":"Abnormal coagulation parameters are associated with poor prognosis in patients with novel coronavirus pneumonia"},{"title3":"Therapeutic and triage strategies for 2019 novel coronavirus disease in fever clinics"},{"title3":"Thrombocytopenia in critically ill patients receiving thromboprophylaxis"},{"title3":"Thrombocytopenia is associated with severe coronavirus disease 2019 (COVID-19) infections: A meta-analysis"},{"title3":"Guidance for diagnosis and treatment of DIC from harmonization of the recommendations from three guidelines. The Scientific Standardization Committee on DIC of the International Society on Thrombosis Haemostasis"},{"title3":"Towards definition, clinical and laboratory criteria, and a scoring system for disseminated intravascular coagulation"},{"title3":"Guidelines for the diagnosis and management of disseminated intravascular coagulation. British Committee for Standards in Haematology"},{"title3":"Diagnosis and treatment of disseminated intravascular coagulation: Guidelines of the Italian Society for Haemostasis and Thrombosis (SISET)"},{"title3":"Sepsis definitions task force. Developing a new definition and assessing new clinical criteria for septic shock: for the third international consensus definitions for sepsis and septic shock (Sepsis-3)"},{"title3":"Diagnosis and management of sepsis-induced coagulopathy and disseminated intravascular coagulation"},{"title3":"New criteria for sepsis-induced coagulopathy (SIC) following the revised sepsis definition: a retrospective analysis of a nationwide survey"},{"title3":"More than an anticoagulant: do heparins have direct anti-inflammatory effects?"}]},{"title2":"Use of D-dimer in oral anticoagulation therapy","References":[]},{"title2":"Abnormal coagulation parameters are associated with poor prognosis in patients with novel coronavirus pneumonia","References":[{"title3":"Abnormal coagulation parameters are associated with poor prognosis in patients with novel coronavirus pneumonia"},{"title3":"Towards definition, clinical and laboratory criteria, and a scoring system for disseminated intravascular coagulation"},{"title3":"Risk factors associated with acute respiratory distress syndrome and death in patients with coronavirus disease 2019 pneumonia in Wuhan, China"},{"title3":"Frequency of thrombocytopenia and heparin-induced thrombocytopenia in patients receiving extracorporeal membrane oxygenation compared with cardiopulmonary bypass and the limited sensitivity of pretest probability score"},{"title3":"Intracranial hemorrhage and early mortality in patients receiving extracorporeal membrane oxygenation for severe respiratory failure"}]},{"title2":"WHO. Clinical management of severe acute respiratory infection when novel coronavirus (nCoV) infection is suspected: interim guidance. 2020.","References":[]},{"title2":"Clinical course and risk factors for mortality of adult inpatients with COVID-19 in Wuhan, China: a retrospective cohort study","References":[{"title3":"The novel coronavirus originating in Wuhan, China: challenges for global health governance"},{"title3":"Severe acute respiratory syndrome-related coronavirus: the species and its viruses:a statement of the Coronavirus Study Group"},{"title3":"Short term outcome and risk factors for adverse clinical outcomes in adults with severe acute respiratory syndrome (SARS)"},{"title3":"Early transmission dynamics in Wuhan, China, of novel coronavirus-infected pneumonia"},{"title3":"Clinical features of patients infected with 2019 novel coronavirus in Wuhan, China"},{"title3":"Clinical characteristics of 138 hospitalized patients with 2019 novel coronavirus-infected pneumonia in Wuhan, China"},{"title3":"Epidemiological and clinical characteristics of 99 cases of 2019 novel coronavirus pneumonia in Wuhan, China: a descriptive study"},{"title3":"Management of adults with hospital-acquired and ventilator-associated pneumonia: 2016 clinical practice guidelines by the Infectious Diseases Society of America and the American Thoracic Society"},{"title3":"KDIGO clinical practice guidelines for acute kidney injury"},{"title3":"Acute respiratory distress syndrome: the Berlin Definition"},{"title3":"Chinese management guideline for COVID-19 (version 6.0)"},{"title3":"Clinical course and outcomes of critically ill patients with SARS-CoV-2 pneumonia in Wuhan, China: a single-centered, retrospective, observational study"},{"title3":"Middle East respiratory syndrome"},{"title3":"Outcomes and prognostic factors in 267 patients with severe acute respiratory syndrome in Hong Kong"},{"title3":"Predictors of mortality in Middle East respiratory syndrome (MERS)"},{"title3":"Exacerbated innate host response to SARS-CoV in aged non-human primates"},{"title3":"The immunopathogenesis of sepsis in elderly patients"},{"title3":"The Third International Consensus Definitions for Sepsis and Septic Shock (Sepsis-3)"},{"title3":"Serial evaluation of the SOFA score to predict outcome in critically ill patients"},{"title3":"Disease severity and clinical outcomes of community-acquired pneumonia caused by non-influenza respiratory viruses in adults: a multicentre prospective registry study from the CAP-China Network"},{"title3":"Community-acquired pneumonia requiring admission to an intensive care unit: a descriptive study"},{"title3":"Acute pneumonia and the cardiovascular system"},{"title3":"Association between influenza vaccination and cardiovascular outcomes in high-risk patients: a meta-analysis"},{"title3":"Laboratory-confirmed respiratory infections as predictors of hospital admission for myocardial infarction and stroke: time-series analysis of English data for 2004-2015"},{"title3":"Prevalence and significance of coagulation abnormalities in community-acquired pneumonia"},{"title3":"D-dimer is a significant prognostic factor in patients with suspected infection and sepsis"},{"title3":"Risk of myocardial infarction and stroke after acute infection or vaccination"},{"title3":"Cardiac complications in patients with community-acquired pneumonia: incidence, timing, risk factors, and association with short-term mortality"},{"title3":"Cardiovascular complications of acute respiratory infections: current research and future directions"},{"title3":"Regulation of ACE2 in cardiac myocytes and fibroblasts"},{"title3":"ACE2 and vasoactive peptides: novel players in cardiovascular/renal remodeling and hypertension"},{"title3":"Pathological findings of COVID-19 associated with acute respiratory distress syndrome"},{"title3":"Persistent shedding of viable SARS-CoV in urine and stool of SARS patients during the convalescent phase"},{"title3":"Viral shedding and antibody response in 37 patients with Middle East Respiratory Syndrome coronavirus infection"},{"title3":"Viral load kinetics of MERS coronavirus infection"},{"title3":"Factors associated with prolonged viral shedding in patients with avian influenza A(H7N9) virus infection"},{"title3":"SARS-CoV-2 viral load in upper respiratory specimens of infected patients"}]},{"title2":"Current and future developments in the treatment of virus-induced hypercytokinemia","References":[{"title3":"Filoviradae: Marburg and Ebola viruses"},{"title3":"Estimation of MERS-Coronavirus reproduction number and case fatality rate for the spring 2014 Saudi Arabia outbreak: insights from publicly available data"},{"title3":"Human infection with highly pathogenic H5N1 influenza virus"},{"title3":"Delayed induction of proinflammatory cytokines and suppression of innate antiviral response by the novel Middle East respiratory syndrome coronavirus: implications for pathogenesis and treatment"},{"title3":"Human fatal Zaire Ebola virus infection is associated with aberrant innate immunity and with massive lymphocyte apoptosis"},{"title3":"Preparing for the next pandemic"},{"title3":"Mapping the innate cascade essential for cytokine storm during influenza virus infection"},{"title3":"Cytokine and viral hemorrhagic fever: potential for therapeutic intervention"},{"title3":"A rationale for using steroids in the treatment of severe cases of H5N1 avian influenza"},{"title3":"The treatment of Crimean-Congo hemorrhagic fever with high-dose methylprednisolone, intravenous immunoglobulin, and fresh frozen plasma"},{"title3":"Fatal outcome of influenza A (H5N1) is associated with high viral load and hypercytokinemia"},{"title3":"Genomic analysis of increased host immune and cell death responses by 1918 influenza virus"},{"title3":"Aberrant innate immune response in lethal infection of macaques with the 1018 influenza virus"},{"title3":"1918 Influenza: the mother of all pandemics"},{"title3":"Inhibition of the cytokine response does not protect against lethal H5N1 influenza infection"},{"title3":"Delayed antiviral plus immunomodulator treatment still reduces mortality in mice infected by high inoculum of influenza A/H5N1 virus"},{"title3":"The cytokine storm of severe influenza and development of immunomodulatory therapy"},{"title3":"Suppression of cytokine storm with a sphingosine analog provides protection against pathogenic influenza virus"},{"title3":"Cytokine storm plays a direct role in the morbidity and mortality from influenza virus infection and is chemically treatable with s single sphingosine-1-phosphate agonist molecule"},{"title3":"A critical role for the sphingosine analog AAL-R in dampening the cytokine response during influenza virus infection"},{"title3":"Influenza A-induced AP-1-dependent gene expression requires activation of JNK signaling pathway"},{"title3":"Regulatory roles of c-Jun in H5N1 influenza virus replication and host inflammation"},{"title3":"RNA cleaving '10-23' DNAzymes with enhanced stability and activity"},{"title3":"Suppression of vascular permeability and inflammation by targeting of transcription factor c-Jun"},{"title3":"Effect of DNAzyme targeting c-Jun on solid tumor growth and angiogenesis in rodents"},{"title3":"Safety and tolerability of an intramumorally injected DNAzyme, Dz13, in patients with nodular basal-cell carcinoma: a Phase I first-in-human trial (DISCOVER)"},{"title3":"Virus-heat protein interaction and a novel axis for innate antiviral immunity"},{"title3":"Short-term heat shock affects host-virus interaction in mice infected with highly pathogenic avian influenza virus H5N1"},{"title3":"Ebola virus disease fact sheet"},{"title3":"Ebola disease outbreak"},{"title3":"Progression of Ebola therapeutics during the 2014-2015 outbreak"},{"title3":"Clinical presentation of patients with Ebola virus disease in Conakry, Guinea"},{"title3":"Myxomavirus-derived serpin prolongs survival and reduces inflammation and hemorrhage in an unrelated lethal mouse viral infection"},{"title3":"Pyridinyl imidazole inhibitors of p38 MAP kinase impair viral entry and reduce cytokine induction by Zaire ebolavirus in human dendritic cells"},{"title3":"Inhibitory specificity of the anti-inflammatory myxoma virus serpin, SERP-1"},{"title3":"The serpin saga: development of a new class of virus derived anti-inflammatory protein therapeutics"},{"title3":"Toremifene interacts and destabilizes the Ebola virus glycoprotein"},{"title3":"Multiplex cytokine profile from Dengue patients: MIP-1beta and IFN-gamma as predictive factors for severity"},{"title3":"Modulation of cytokine and cytokine receptor/antagonist by treatment with doxycycline and tetracycline in patients with Dengue fever"},{"title3":"Immunomodulatory properties of antibiotics"},{"title3":"Combinational computational approaches to identify tetracycline derivatives as flavivirus inhibitors"},{"title3":"Cytokine kinetics of Zika virus-infected patients from acute to reconvalescent phase"},{"title3":"Dengue virus immunopathogensis: lessons applicable to the emergence of Zika virus"}]},{"title2":"Coagulation and sepsis","References":[]},{"title2":"The stimulation of thrombosis by hypoxia","References":[]},{"title2":"Anticoagulant treatment is associated with decreased mortality in severe coronavirus disease 2019 patients with coagulopathy","References":[{"title3":"The SOFA (Sepsis-related Organ Failure Assessment) score to describe organ dysfunction/failure. On behalf of the working group on sepsis-related problems of the European society of intensive care medicine"},{"title3":"New criteria for sepsis-induced coagulopathy (SIC) following the revised sepsis definition: a retrospective analysis of a nationwide survey"}]},{"title2":"D-dimer concentration increases with age reducing the clinical value of the D-dimer assay in the elderly","References":[]},{"title2":"A risk assessment model for the identification of hospitalized medical patients at risk for venous thromboembolism: the Padua Prediction Score","References":[]},{"title2":"Inflammation and thrombosis in diabetes","References":[{"title3":"Islet beta cell failure in type 2 diabetes"},{"title3":"Beta-cell failure as a complication of diabetes"},{"title3":"Beta cell dysfunction and insulin resistance"},{"title3":"Insulin resistance in type 1 diabetes: what is 'double diabetes' and what are the risks?"},{"title3":"Association of cardiometabolic multimorbidity with mortality"},{"title3":"Relation between age and cardiovascular disease in men and women with diabetes compared with non-diabetic people: a population-based retrospective cohort study"},{"title3":"Endothelial dysfunction: cardiovascular risk factors, therapy, and outcome"},{"title3":"Coagulation and atherothrombotic disease"},{"title3":"Hypoglycaemia, thrombosis and vascular events in diabetes"},{"title3":"Role of endothelial dysfunction in atherosclerosis"},{"title3":"Endothelial function and dysfunction: testing and clinical relevance"},{"title3":"The vascular endothelium and human diseases"},{"title3":"Endothelial cell dysfunction and the pathobiology of atherosclerosis"},{"title3":"Diabetes and vascular disease: pathophysiology, clinical consequences, and medical therapy: part I"},{"title3":"Obesity and diabetes in the developing world - a growing challenge"},{"title3":"Reciprocal relationships between insulin resistance and endothelial dysfunction: molecular and pathophysiological mechanisms"},{"title3":"The importance of endothelin-1 for microvascular dysfunction in diabetes"},{"title3":"Phenotypic switching of vascular smooth muscle cells in the 'normal region' of aorta from atherosclerosis patients is regulated by miR-145"},{"title3":"Arterial stiffness: a brief review"},{"title3":"Reduced vascular NO bioavailability in diabetes increases platelet activation in vivo"},{"title3":"Oxidative stress and diabetic complications"},{"title3":"Endothelial dysfunction in diabetes mellitus: molecular mechanisms and clinical implications"},{"title3":"Platelet activation in type 2 diabetes mellitus"},{"title3":"Factors contributing to increased platelet reactivity in people with diabetes"},{"title3":"Platelet abnormalities in diabetes mellitus"},{"title3":"Antithrombotic therapy for secondary prevention in patients with diabetes mellitus and coronary artery disease"},{"title3":"Greater clinical benefit of more intensive oral antiplatelet therapy with prasugrel in patients with diabetes mellitus in the trial to assess improvement in therapeutic outcomes by optimizing platelet inhibition with prasugrel-thrombolysis in myocardial infarction 38"},{"title3":"Impact of glycoprotein IIb/IIIa inhibitors on the efficacy and safety of ticagrelor compared with clopidogrel in patients with acute coronary syndromes: analysis from the platelet inhibition and patient outcomes (PLATO) trial"},{"title3":"Safety and efficacy of ticagrelor and clopidogrel in primary percutaneous coronary intervention"},{"title3":"Reduction in first and recurrent cardiovascular events with ticagrelor compared with clopidogrel in the PLATO study"},{"title3":"Ticagrelor vs. clopidogrel in patients with acute coronary syndromes and diabetes: a substudy from the platelet inhibition and patient outcomes (PLATO) trial"},{"title3":"Reduction in ischemic events with ticagrelor in diabetic patients with prior myocardial infarction in PEGASUS-TIMI 54"},{"title3":"Randomized controlled trial comparing impact on platelet reactivity of twice-daily with once-daily aspirin in people with type 2 diabetes"},{"title3":"Biological efficacy of twice daily aspirin in type 2 diabetic patients with coronary artery disease"},{"title3":"Twice daily dosing of aspirin improves platelet inhibition in whole blood in patients with type 2 diabetes mellitus and micro- or macrovascular complications"},{"title3":"Pharmacodynamic effects of different aspirin dosing regimens in type 2 diabetes mellitus patients with coronary artery disease"},{"title3":"Cholesterol efflux in megakaryocyte progenitors suppresses platelet production and thrombocytosis"},{"title3":"Reticulated platelets and uninhibited COX-1 and COX-2 decrease the antiplatelet effects of aspirin"},{"title3":"Immature platelet fraction (IPF) determined with an automated method predicts clopidogrel hyporesponsiveness"},{"title3":"Newly formed reticulated platelets undermine pharmacokinetically short-lived antiplatelet therapies"},{"title3":"Neutrophil-derived S100 calcium-binding proteins A8/A9 promote reticulated thrombocytosis and atherogenesis in diabetes"},{"title3":"SGLT2 inhibitors through the windows of EMPA-REG and CANVAS trials: a review"},{"title3":"Coagulation and fibrinolysis in diabetes"},{"title3":"Hypofibrinolysis in diabetes: a therapeutic target for the reduction of cardiovascular risk"},{"title3":"Diabetes and vascular disease: pathophysiology, clinical consequences, and medical therapy: part I"},{"title3":"PAI-1 and diabetes: a journey from the bench to the bedside"},{"title3":"Increased incorporation of antiplasmin into the fibrin network in patients with type 1 diabetes"},{"title3":"Increased oxidation as an additional mechanism underlying reduced clot permeability and impaired fibrinolysis in type 2 diabetes"},{"title3":"Glycation of fibrinogen in uncontrolled diabetic patients and the effects of glycaemic control on fibrinogen glycation"},{"title3":"Acetylation and glycation of fibrinogen in vitro occur at specific lysine residues in a concentration dependent manner: a mass spectrometric and isotope labeling study"},{"title3":"The effect of glycaemic control on fibrin network structure of type 2 diabetic subjects"},{"title3":"Diabetes is associated with posttranslational modifications in plasminogen resulting in reduced plasmin generation and enzyme-specific activity"},{"title3":"Serpin regulation of fibrinolytic system: implications for therapeutic applications in cardiovascular diseases"},{"title3":"Complement C3 is a novel plasma clot component with anti-fibrinolytic properties"},{"title3":"A novel mechanism for hypofibrinolysis in diabetes: the role of complement C3"},{"title3":"Hypofibrinolysis in type 2 diabetes: the role of the inflammatory pathway and complement C3"},{"title3":"The influence of type 2 diabetes on fibrin clot properties in patients with coronary artery disease"},{"title3":"Statins in atherosclerosis: lipid-lowering agents with antioxidant capabilities"},{"title3":"Inflammation, immunity, and HMG-CoA reductase inhibitors: statins as antiinflammatory agents?"},{"title3":"HMG-CoA reductase inhibitors for lowering elevated levels of C-reactive protein"},{"title3":"STABILITY and SOLID-TIMI 52: lipoprotein associated phospholipase A2 (Lp-PLA2) as a biomarker or risk factor for cardiovascular diseases"},{"title3":"Anti-inflammatory therapeutics for the treatment of atherosclerosis"},{"title3":"Phospholipase A2 enzymes and the risk of atherosclerosis"},{"title3":"Antioxidants, inflammation and cardiovascular disease"},{"title3":"Effects of succinobucol (AGI-1067) after an acute coronary syndrome: a randomised, double-blind, placebo-controlled trial"},{"title3":"European contribution to the study of ROS: a summary of the findings and prospects for the future from the COST action BM1203 (EU-ROS)"},{"title3":"Soluble guanylate cyclase as an emerging therapeutic target in cardiopulmonary disease"},{"title3":"A soluble guanylate cyclase activator inhibits the progression of diabetic nephropathy in the ZSF1 rat"},{"title3":"Effects of calcium channel blockers on glucose tolerance, inflammatory state, and circulating progenitor cells in non-diabetic patients with essential hypertension: a comparative study between azelnidipine and amlodipine on glucose tolerance and endothelial function - a crossover trial (AGENT)"},{"title3":"Effects of atorvastatin, amlodipine, and their combination on vascular dysfunction in insulin-resistant rats"},{"title3":"Pioglitazone vs glimepiride: differential effects on vascular endothelial function in patients with type 2 diabetes"},{"title3":"Endothelial dysfunction as a target for prevention of cardiovascular disease"},{"title3":"Secondary prevention of macrovascular events in patients with type 2 diabetes in the PROactive study (PROspective pioglitAzone Clinical Trial In macroVascular Events): a randomised controlled trial"},{"title3":"Rosiglitazone revisited: an updated meta-analysis of risk for myocardial infarction and cardiovascular mortality"},{"title3":"Improvement of vascular function by acute and chronic treatment with the PDE-5 inhibitor sildenafil in experimental diabetes mellitus"},{"title3":"Endothelial nitric oxide synthase enhancer reduces oxidative stress and restores endothelial function in db/db mice"},{"title3":"AVE3085, an enhancer of endothelial nitric oxide synthase, restores endothelial function and reduces blood pressure in spontaneously hypertensive rats"},{"title3":"Vascular endothelial dysfunction and pharmacological treatment"},{"title3":"Sphingosine-1-phosphate signaling and its role in disease"},{"title3":"Diabetes and ageing-induced vascular inflammation"},{"title3":"High-density lipoprotein delivered after myocardial infarction increases cardiac glucose uptake and function in mice"},{"title3":"MicroRNAs and cardiovascular disease in diabetes mellitus"},{"title3":"Elevated microRNA-155 promotes foam cell formation by targeting HBP1 in atherogenesis"},{"title3":"The role of microRNAs in diabetic complications-special emphasis on wound healing"},{"title3":"Dicer cleavage by calpain determines platelet microRNA levels and function in diabetes"},{"title3":"Intensified insulin-based glycaemic control after myocardial infarction: mortality during 20 year follow-up of the randomised diabetes mellitus insulin glucose infusion in acute myocardial infarction (DIGAMI 1) trial"},{"title3":"The relationship between glycaemic variability and cardiovascular complications in patients with acute myocardial infarction and type 2 diabetes: a report from the DIGAMI 2 trial"},{"title3":"Intensive glycemic control and the prevention of cardiovascular events: implications of the ACCORD, ADVANCE, and VA diabetes trials: a position statement of the American Diabetes Association and a scientific statement of the American College of Cardiology Foundation and the American Heart Association"},{"title3":"Effect of hypoglycaemia on thrombosis and inflammation in patients with type 2 diabetes"},{"title3":"An observational study of patient characteristics and mortality following hypoglycemia in the community"},{"title3":"Severe hypoglycaemia and cardiovascular disease: systematic review and meta-analysis with bias analysis"},{"title3":"Empagliflozin, cardiovascular outcomes, and mortality in type 2 diabetes"},{"title3":"Liraglutide and cardiovascular outcomes in type 2 diabetes"},{"title3":"Canagliflozin and cardiovascular and renal events in type 2 diabetes"},{"title3":"Treatment with high-dose n-3 PUFAs has no effect on platelet function, coagulation, metabolic status or inflammation in patients with atherosclerosis and type 2 diabetes"},{"title3":"Platelet function profiles in patients with diabetes mellitus"},{"title3":"Diabetes and antiplatelet therapy in acute coronary syndrome"},{"title3":"Antithrombotic properties of aspirin and resistance to aspirin: beyond strictly antiplatelet actions"},{"title3":"Effects of aspirin on clot structure and fibrinolysis using a novel in vitro cellular system"},{"title3":"Primary prevention of cardiovascular events with low-dose aspirin and vitamin E in type 2 diabetic patients: results of the primary prevention project (PPP) trial"},{"title3":"Low-dose aspirin for primary prevention of cardiovascular events in patients with type 2 diabetes mellitus: 10-year follow-up of a randomized controlled trial"},{"title3":"The prevention of progression of arterial disease and diabetes (POPADAD) trial: factorial randomised placebo controlled trial of aspirin and antioxidants in patients with diabetes and asymptomatic peripheral arterial disease"},{"title3":"ESC guidelines on diabetes, pre-diabetes, and cardiovascular diseases developed in collaboration with the EASD: the Task Force on diabetes, pre-diabetes, and cardiovascular diseases of the European Society of Cardiology (ESC) and developed in collaboration with the European Association for the Study of Diabetes (EASD)"},{"title3":"Platelet reactivity and response to aspirin in subjects with the metabolic syndrome"},{"title3":"A pharmacodynamic comparison of prasugrel vs. high-dose clopidogrel in patients with type 2 diabetes mellitus and coronary artery disease: results of the Optimizing anti-Platelet Therapy in diabetes MellitUS (OPTIMUS)-3 trial"},{"title3":"The clinical efficacy and safety evaluation of ticagrelor for acute coronary syndrome in general ACS patients and diabetic patients: a systematic review and meta-analysis"},{"title3":"Effects of dabigatran on the cellular and protein phase of coagulation in patients with coronary artery disease on dual antiplatelet therapy with aspirin and clopidogrel. Results from a prospective, randomised, double-blind, placebo-controlled study"},{"title3":"New fundamentals in hemostasis"},{"title3":"Efficacy and safety of enoxaparin versus unfractionated heparin during percutaneous coronary intervention: systematic review and meta-analysis"},{"title3":"Fondaparinux and acute coronary syndromes: update on the OASIS 5-6 studies"},{"title3":"Bivalirudin or unfractionated heparin in acute coronary syndromes"},{"title3":"Safety and efficacy of bivalirudin monotherapy in patients with diabetes mellitus and acute coronary syndromes: a report from the ACUITY (acute catheterization and urgent intervention triage strategy) trial"},{"title3":"Rivaroxaban with or without aspirin in stable cardiovascular disease"},{"title3":"Selective depletion of plasma prekallikrein or coagulation factor XII inhibits thrombosis in mice without increased risk of bleeding"},{"title3":"Emerging anticoagulant strategies"}]},{"title2":"National Health Commission of the People's Republic of China. Chinese management guideline for covid-19 (version 6.0). http://www.nhc.gov.cn/yzygj/s7653p/202002/8334a8326dd94d329df351d7da8aefc2/fles/b218cfeb1bc54639af227f922bf6b817.pdf","References":[]},{"title2":"Diagnosis and management of sepsis-induced coagulopathy and disseminated intravascular coagulation","References":[]},{"title2":"D-dimer to guide the intensity of anticoagulation in Chinese patients after mechanical heart valve replacement: a randomized controlled trial","References":[]},{"title2":"D-dimer testing in laboratory practice","References":[]},{"title2":"The early course of D-dimer concentration following pulmonary artery embolisation","References":[]}]},{"title1":"Predictors of mortality for patients with COVID-19 pneumonia caused by SARS-CoV-2: a prospective cohort study","References":[{"title2":"A novel coronavirus from patients with pneumonia in China, 2019","References":[{"title3":"Clinical features of patients infected with 2019 novel coronavirus in Wuhan, China"},{"title3":"A familial cluster of pneumonia associated with the 2019 novel coronavirus indicating person-to-person transmission: a study of a family cluster"},{"title3":"Epidemiological and clinical characteristics of 99 cases of 2019 novel coronavirus pneumonia in Wuhan, China: a descriptive study"},{"title3":"A novel coronavirus from patients with pneumonia in China, 2019"},{"title3":"Inferring the hosts of coronavirus using dual statistical models based on nucleotide composition"},{"title3":"Importation and human-to-human transmission of a novel coronavirus in Vietnam"},{"title3":"2019 novel coronavirus (2019-nCoV) outbreak: a new challenge"},{"title3":"Clinical Characteristics of 138 Hospitalized Patients With 2019 Novel Coronavirus-Infected Pneumonia in Wuhan"},{"title3":"Identification of a novel coronavirus causing severe pneumonia in human: a descriptive study"},{"title3":"A new coronavirus associated with human respiratory disease in China"},{"title3":"Measures for diagnosing and treating infections by a novel coronavirus responsible for a pneumonia outbreak originating in Wuhan, China"},{"title3":"Novel Wuhan (2019-nCoV) coronavirus"},{"title3":"Severe acute respiratory syndrome coronavirus phylogeny: toward consensus"},{"title3":"Diagnosis and treatment of new coronavirus pneumonia (trial version 7) [J / OL]. Tianjin J Tradit Chin Med. 2020;1-5. http://kns.cnki.net/kcms/detail/12.1349.R.20200304.1638.006.html. Accessed 3 June 2020."},{"title3":"Clinical outcome of standardized oxygen therapy nursing strategy in COVID-19"},{"title3":"Radiological findings from 81 patients with COVID-19 pneumonia in Wuhan, China: a descriptive study"},{"title3":"Evolution of the novel coronavirus from the ongoing Wuhan outbreak and modeling of its spike protein for risk of human transmission"},{"title3":"Angiotensin-converting enzyme 2: a functional receptor for SARS coronavirus"},{"title3":"Single-cell RNA-seq data analysis on the receptor ACE2 expression reveals the potential risk of different human organs vulnerable to 2019-nCoV infection"},{"title3":"High expression of ACE2 receptor of 2019-nCoV on the epithelial cells of oral mucosa"},{"title3":"Tissue distribution of ACE2 protein, the functional receptor for SARS coronavirus. A first step in understanding SARS pathogenesis"},{"title3":"Cryo-EM structure of the 2019-nCoV spike in the prefusion conformation"},{"title3":"Organ distribution of severe acute respiratory syndrome (SARS) associated coronavirus (SARS-CoV) in SARS patients: implications for pathogenesis and virus transmission pathways"},{"title3":"Significant changes of peripheral T lymphocyte subsets in patients with severe acute respiratory syndrome"},{"title3":"Overlapping and discrete aspects of the pathology and pathogenesis of the emerging human pathogenic coronaviruses SARS-CoV, MERS-CoV, and 2019-nCoV"},{"title3":"Lactate dehydrogenase and C-reactive protein as predictors of respiratory failure in CoVID-19 patients"},{"title3":"Lactate dehydrogenase, an independent risk factor of severe COVID-19 patients: a retrospective and observational study"},{"title3":"C-reactive protein correlates with computed tomographic findings and predicts severe COVID-19 early"},{"title3":"Eosinopenia and elevated C-reactive protein facilitate triage of COVID-19 patients in fever clinic: a retrospective case-control study"},{"title3":"Association of cardiac injury with mortality in hospitalized patients with COVID-19 in Wuhan, China"},{"title3":"Cardiovascular implications of fatal outcomes of patients with coronavirus disease 2019 (COVID-19)"},{"title3":"Clinical course and risk factors for mortality of adult inpatients with COVID-19 in Wuhan, China: a retrospective cohort study"},{"title3":"Human ipsc-derived cardiomyocytes are susceptible to Sars-Cov-2 infection"},{"title3":"Cardiovascular complications in COVID-19"},{"title3":"COVID-19 pandemic and troponin: indirect myocardial injury, myocardial inflammation or myocarditis?"},{"title3":"Endothelial cell infection and endotheliitis in COVID-19"}]},{"title2":"Early transmission dynamics in Wuhan, China, of novel coronavirus-infected pneumonia","References":[{"title3":"The 2019-nCoV Outbreak Joint Field Epidemiology Investigation Team, Li Q. Notes from the field: an outbreak of NCIP (2019-nCoV) infection in China : Wuhan, Hubei Province, 2019-2020."},{"title3":"A novel coronavirus genome identified in a cluster of pneumonia cases : Wuhan, China 2019-2020."},{"title3":"A novel coronavirus from patients with pneumonia in China, 2019."},{"title3":"Use of national pneumonia surveillance to describe influenza A(H7N9) virus epidemiology, China, 2004-2013."},{"title3":"A novel coronavirus emerging in China : key questions for impact assessment."},{"title3":"Evidence for camel-to-human transmission of MERS coronavirus."},{"title3":"Transmission dynamics and control of severe acute respiratory syndrome."},{"title3":"Dynamically modeling SARS and other newly emerging respiratory illnesses: past, present, and future."},{"title3":"Coronavirus infections : more than just the common cold."},{"title3":"Another decade, another coronavirus."},{"title3":"SARS and MERS: recent insights into emerging coronaviruses."},{"title3":"MERS, SARS, and Ebola: the role of super-spreaders in infectious disease."},{"title3":"A familial cluster of pneumonia associated with the 2019 novel coronavirus indicating person-to-person transmission: a study of a family cluster."},{"title3":"Real-time tentative assessment of the epidemiological characteristics of novel coronavirus infections in Wuhan, China, as at January 2020."},{"title3":"How to maintain surveillance for novel influenza A H1N1 when there are too many cases to count."}]},{"title2":"Nowcasting and forecasting the potential domestic and international spread of the 2019-nCoV outbreak originating in Wuhan, China: a modelling study","References":[{"title3":"Superspreading and the effect of individual variation on disease emergence"},{"title3":"Model parameters and outbreak control for SARS"},{"title3":"Transmission dynamics of the etiological agent of SARS in Hong Kong: impact of public health interventions"},{"title3":"Transmission dynamics and control of severe acute respiratory syndrome"},{"title3":"Transmission characteristics of MERS and SARS in the healthcare setting: a comparative study"},{"title3":"The role of superspreading in Middle East respiratory syndrome coronavirus (MERS-CoV) transmission"},{"title3":"Unraveling the drivers of MERS-CoV transmission"},{"title3":"MERS transmission and risk factors: a systematic review"},{"title3":"Clinical impact of human coronaviruses 229E and OC43 infection in diverse adult populations"},{"title3":"Epidemiology characteristics of human coronaviruses in patients with respiratory infection symptoms and phylogenetic analysis of HCoV-OC43 during 2010-2015 in Guangzhou"},{"title3":"Epidemiology and clinical presentations of the four human coronaviruses 229E, HKU1, NL63, and OC43 detected over 3 years using a novel multiplex real-time PCR method"},{"title3":"The epidemiology of severe acute respiratory syndrome in the 2003 Hong Kong epidemic: an analysis of all 1755 patients"},{"title3":"A comparative epidemiologic analysis of SARS in Hong Kong, Beijing and Taiwan"},{"title3":"Comparison of incubation period distribution of human infections with MERS-CoV in South Korea and Saudi Arabia"},{"title3":"Complete genomic sequence of human coronavirus OC43: molecular clock analysis suggests a relatively recent zoonotic coronavirus transmission event"},{"title3":"Incubation periods of acute respiratory viral infections: a systematic review"},{"title3":"Preliminary epidemiological assessment of MERS-CoV outbreak in South Korea, May to June 2015"},{"title3":"Seroprevalence of IgG antibodies to SARS-coronavirus in asymptomatic or subclinical population groups"},{"title3":"Comparative serological study for the prevalence of anti-MERS coronavirus antibodies in high-and low-risk groups in Qatar"},{"title3":"Middle East respiratory syndrome coronavirus (MERS-CoV) neutralising antibodies in a high-risk human population, Morocco, November 2017 to January 2018"},{"title3":"Development and application of an enzyme immunoassay for coronavirus OC43 antibody in acute respiratory illness"},{"title3":"Examination of seroprevalence of coronavirus HKU1 infection with S protein-based ELISA and neutralization assay against viral spike pseudotyped virus"},{"title3":"Middle East respiratory syndrome: what we learned from the 2015 outbreak in the Republic of Korea"},{"title3":"An outbreak of human coronavirus OC43 infection and serological cross-reactivity with SARS coronavirus"},{"title3":"Human coronavirus alone or in co-infection with rhinovirus C is a risk factor for severe respiratory disease and admission to the pediatric intensive care unit: a one-year study in Southeast Brazil"},{"title3":"Case fatality of SARS in mainland China and associated risk factors"},{"title3":"Interhuman transmissibility of Middle East respiratory syndrome coronavirus: estimation of pandemic risk"},{"title3":"Middle East respiratory syndrome coronavirus: quantification of the extent of the epidemic, surveillance biases, and transmissibility"},{"title3":"The SARS epidemic in Hong Kong: what lessons have we learned?"},{"title3":"SARS in healthcare facilities, Toronto and Taiwan"},{"title3":"Wuhan is expected to send 15 million passengers during Spring Festival in 2020 (in Chinese)"},{"title3":"An outbreak of NCIP (2019-nCoV) infection in China:Wuhan, Hubei Province, 2019-2020"},{"title3":"Early transmission dynamics in Wuhan, China, of novel coronavirus-infected pneumonia"},{"title3":"Characterizing the dynamics underlying global spread of epidemics"},{"title3":"The effect of public health measures on the 1918 influenza pandemic in U.S. cities"},{"title3":"Frequently asked questions about SARS"},{"title3":"Real-time epidemic forecasting: challenges and opportunities"},{"title3":"Outbreak analytics: a developing data science for informing the response to emerging pathogens"},{"title3":"Improving the evidence base for decision making during a pandemic: the example of 2009 influenza A/H1N1"},{"title3":"MRC Centre for Global Infectious Disease Analysis: Wuhan coronavirus reports 1-3"},{"title3":"Novel coronavirus 2019-nCoV: early estimation of epidemiological parameters and epidemic predictions"},{"title3":"Transmission dynamics of 2019 novel coronavirus (2019-nCoV)"},{"title3":"Preliminary estimation of the basic reproduction number of novel coronavirus (2019-nCoV) in China, from 2019 to 2020: a data-driven analysis in the early phase of the outbreak"},{"title3":"Announcement of the State Administration of Market Supervision, Ministry of Agriculture and Rural Affairs, and the National Forestry and Grass Bureau on banning wildlife trading (in Chinese)"}]},{"title2":"More than 20,000 medical staff were sent to Hubei Province","References":[]},{"title2":"Wuhan coronavirus (2019-nCoV) global cases","References":[]},{"title2":"Coronavirus infections - more than just the common cold","References":[]},{"title2":"Characteristics of and important lessons from the coronavirus disease 2019 (COVID-19) outbreak in China: summary of a report of 72 314 cases from the Chinese Center for Disease Control and Prevention","References":[]},{"title2":"Clinical features of patients infected with 2019 novel coronavirus in Wuhan, China","References":[{"title3":"A familial cluster of pneumonia associated with the 2019 novel coronavirus indicating person-to-person transmission: a study of a family cluster"},{"title3":"A familial cluster of pneumonia associated with the 2019 novel coronavirus indicating person-to-person transmission: a study of a family cluster"},{"title3":"Epidemiological and clinical characteristics of 99 cases of 2019 novel coronavirus pneumonia in Wuhan, China: adescriptivestudy"},{"title3":"Epidemiological and clinical characteristics of 99 cases of 2019 novel coronavirus pneumonia in Wuhan, China: a descriptive study"},{"title3":"First case of 2019 novel coronavirus in the United States"},{"title3":"Clinical features of patients infected with 2019 novel coronavirus in Wuhan, China"},{"title3":"Lung CT image of a confirmed case of the 2019 novel coronavirus (2019-nCoV) infected pneumonia (With differential diagnosis of the SARS)"},{"title3":"Early transmission dynamics in Wuhan, China, of novel coronavirus-infected pneumonia"},{"title3":"Role of neutrophil to lymphocyte and monocyte to lymphocyte ratios in the diagnosis of bacterial infection in patients with fever"},{"title3":"Coronavirus infections-more than just the common cold"},{"title3":"The association between the neutrophil-to-lymphocyte ratio and mortality in critical illness: an observational cohort study"},{"title3":"A new coronavirus associated with human respiratory disease in China"},{"title3":"Monocyte/lymphocyte ratio as a better predictor of cardiovascular and all-cause mortality in hemodialysis patients: a prospective cohort study"},{"title3":"Ratio of neutrophil to lymphocyte counts-rapid and simple parameter of systemic inflammation and stress in critically ill"},{"title3":"Neutrophil-lymphocyte ratio as an early new marker in AIV-H7N9-infected patients: a retrospective study"}]},{"title2":"Epidemiological and clinical characteristics of 99 cases of 2019 novel coronavirus pneumonia in Wuhan, China: a descriptive study","References":[{"title3":"Outbreak of pneumonia of unknown etiology in Wuhan China: the mystery and the miracle"},{"title3":"The continuing 2019-nCoV epidemic threat of novel coronaviruses to global health - the latest 2019 novel coronavirus outbreak in Wuhan, China"},{"title3":"Clinical features of patients infected with 2019 novel coronavirus in Wuhan, China"},{"title3":"Clinical management of severe acute respiratory infection when Novel coronavirus (nCoV) infection is suspected: interim guidance"},{"title3":"MERS, SARS and other coronaviruses as causes of pneumonia"},{"title3":"Identification of a novel coronavirus in patients with severe acute respiratory syndrome"},{"title3":"Isolation of a novel coronavirus from a man with pneumonia in Saudi Arabia"},{"title3":"Clinical features predicting mortality risk in patients with viral pneumonia: the MuLBSTA score"},{"title3":"Discovery of a rich gene pool of bat SARS-related coronaviruses provides new insights into the origin of SARS coronavirus"},{"title3":"Cross-host evolution of severe acute respiratory syndrome coronavirus in palm civet and human"},{"title3":"Middle East respiratory syndrome coronavirus in dromedary camels: an outbreak investigation"},{"title3":"Evidence for camel-to-human transmission of MERS coronavirus"},{"title3":"Surveillance of bat coronaviruses in Kenya identifies relatives of human coronaviruses NL63 and 229E and their recombination history"},{"title3":"Origin and evolution of pathogenic coronaviruses"},{"title3":"Fatal swine acute diarrhoea syndrome caused by an HKU2-related coronavirus of bat origin"},{"title3":"Evolution of the novel coronavirus from the ongoing Wuhan outbreak and modeling of its spike protein for the risk of human transmission"},{"title3":"Wuhan coronavirus has strong ability to infect humans. Press release"},{"title3":"From SARS to MERS, thrusting coronaviruses into the spotlight"},{"title3":"Prevalence of comorbidities in the Middle East respiratory syndrome coronavirus (MERS-CoV): a systematic review and meta-analysis"},{"title3":"Sex-based differences in susceptibility to severe acute respiratory syndrome coronavirus infection"},{"title3":"Sexual dimorphism in innate immunity"},{"title3":"Pathophysiology and burden of infection in patients with diabetes mellitus and peripheral vascular disease: focus on skin and soft-tissue infections"},{"title3":"Clinical findings in 111 cases of influenza A (H7N9) virus infection"},{"title3":"Clinical features of three avian influenza H7N9 virus-infected patients in Shanghai"},{"title3":"T-cell immunity of SARS-CoV: implications for vaccine development against MERS-CoV"}]},{"title2":"Clinical characteristics of 138 hospitalized patients with 2019 novel coronavirus-infected pneumonia in Wuhan, China","References":[]},{"title2":"Clinical management of severe acute respiratory infection when novel coronavirus (nCoV) infection is suspected: interim guidance","References":[]},{"title2":"Clinical characteristics of coronavirus disease 2019 in China","References":[{"title3":"Early transmission dynamics in Wuhan, China, of novel coronavirus-infected pneumonia."},{"title3":"Challenges in laboratory diagnosis of the novel coronavirus SARS-CoV-2."},{"title3":"Clinical features of patients infected with 2019 novel coronavirus in Wuhan, China."},{"title3":"First case of 2019 novel Coronavirus in the United States."},{"title3":"Epidemiological and clinical characteristics of 99 cases of 2019 novel coronavirus pneumonia in Wuhan, China: a descriptive study."},{"title3":"A novel coronavirus associated with severe acute respiratory syndrome."},{"title3":"A preventive and control strategy for COVID-19 infection: an experience from a Third-Tier Chinese City."},{"title3":"An emerging coronavirus causing pneumonia outbreak in Wuhan, China: calling for developing therapeutic and prophylactic strategies."},{"title3":"Measures for diagnosing and treating infections by a novel coronavirus responsible for a pneumonia outbreak originating in Wuhan, China."},{"title3":"Perspectives on therapeutic neutralizing antibodies against the Novel Coronavirus SARS-CoV-2."},{"title3":"COVID-19, an emerging coronavirus infection: advances and prospects in designing and developing vaccines, immunotherapeutics, and therapeutics."},{"title3":"Transplantation of ACE2(-) mesenchymal stem cells improves the outcome of patients with COVID-19 pneumonia."},{"title3":"On the use of corticosteroids for 2019-nCoV pneumonia."},{"title3":"Comprehensive analysis of drugs to treat SARSCoV2 infection: mechanistic insights into current COVID19 therapies (Review)."},{"title3":"The role of telemedicine during the COVID-19 epidemic in China-experience from Shandong province."},{"title3":"Human umbilical cord-derived mesenchymal stem cell therapy in patients with COVID-19: a phase 1 clinical trial."},{"title3":"Intravenous infusion of human umbilical cord Wharton's jelly-derived mesenchymal stem cells as a potential treatment for patients with COVID-19 pneumonia."},{"title3":"Flattening the COVID-19 curve with natural killer cell based immunotherapies."},{"title3":"A familial cluster of pneumonia associated with the 2019 novel coronavirus indicating person-to-person transmission: a study of a family cluster."},{"title3":"Full-genome evolutionary analysis of the novel corona virus (2019-nCoV) rejects the hypothesis of emergence as a result of a recent recombination event."},{"title3":"Epidemiologic and clinical characteristics of novel coronavirus infections involving 13 patients outside Wuhan, China."},{"title3":"Spatio-temporal metabolokinetics and efficacy of human placenta-derived mesenchymal stem/stromal cells on mice with refractory Crohn's-like enterocutaneous fistula."},{"title3":"High-efficient generation of VCAM-1(+) mesenchymal stem cells with multidimensional superiorities in signatures and efficacy on aplastic anaemia mice."},{"title3":"Systematic comparison of hUC-MSCs at various passages reveals the variations of signatures and therapeutic effect on acute graft-versus-host disease."},{"title3":"JNKi- and DAC-programmed mesenchymal stem/stromal cells from hESCs facilitate hematopoiesis and alleviate hind limb ischemia."},{"title3":"Identification of a novel coronavirus in patients with severe acute respiratory syndrome."},{"title3":"Studies on viral pneumonia related to novel coronavirus SARS-CoV-2, SARS-CoV, and MERS-CoV: a literature review."},{"title3":"Three emerging coronaviruses in two decades."},{"title3":"The epidemic of 2019-novel-coronavirus (2019-nCoV) pneumonia and insights for emerging infectious diseases in the future."},{"title3":"Coronaviruses - drug discovery and therapeutic options."},{"title3":"The pathogenicity of SARS-CoV-2 in hACE2 transgenic mice."},{"title3":"Acute respiratory distress syndrome: the Berlin Definition."},{"title3":"Pediatric acute respiratory distress syndrome: definition, incidence, and epidemiology: proceedings from the Pediatric Acute Lung Injury Consensus Conference."},{"title3":"Eicosanoid storm in infection and inflammation."},{"title3":"Decoding the enigma of antiviral crisis: does one target molecule regulate all?"}]},{"title2":"Another decade, another coronavirus","References":[{"title3":"Report of the WHO-China Joint Mission on Coronavirus Disease 2019 (COVID-19)"},{"title3":"WHO Director-General's Opening Remarks at the Media Briefing on COVID-19:11 March 2020"},{"title3":"Covid-19, Situation in Italy"},{"title3":"The Coming Coronavirus Crisis: What Can We Learn?"},{"title3":"Information Overload in Consumers of Health-Related Information: A Scoping Review Protocol"},{"title3":"Mental Health Problems and Social Media Exposure during COVID-19 Outbreak"},{"title3":"Transmission Routes of 2019-NCoV and Controls in Dental Practice"},{"title3":"Coronavirus Disease 2019 (COVID-19): Emerging and Future Challenges for Dental and Oral Medicine"},{"title3":"Being a Front-Line Dentist during the Covid-19 Pandemic: A Literature Review"},{"title3":"COVID-19 Transmission in Dental Practice: Brief Review of Preventive Measures in Italy"},{"title3":"Persistence of Coronaviruses on Inanimate Surfaces and Their Inactivation with Biocidal Agents"},{"title3":"Consumer Understanding, Perceptions and Behaviours with Regard to Environmentally Friendly Packaging in a Developing Nation"},{"title3":"Epidemiological Aspects and Psychological Reactions to COVID-19 of Dental Practitioners in the Northern Italy Districts of Modena and Reggio Emilia"},{"title3":"Fear and Practice Modifications among Dentists to Combat Novel Coronavirus Disease (COVID-19) Outbreak"},{"title3":"COVID-19 Factors and Psychological Factors Associated with Elevated Psychological Distress among Dentists and Dental Hygienists in Israel"},{"title3":"COVID-19 Outbreak Perception in Italian Dentists"},{"title3":"Impact of Coronavirus Pandemic in Appointments and Anxiety/Concerns of Patients Regarding Orthodontic Treatment"},{"title3":"Immediate and Sustained Psychological Impact of an Emerging Infectious Disease Outbreak on Health Care Workers"},{"title3":"Knowledge of and Attitudes toward Severe Acute Respiratory Syndrome among a Cohort of Dental Patients in Hong Kong Following a Major Local Outbreak"},{"title3":"Knowledge and Apprehension of Dental Patients about MERS-A Questionnaire Survey"},{"title3":"Italy: Health System Review"},{"title3":"The Healthcare System and the Provision of Oral Healthcare in European Union Member States. Part 8: Italy"},{"title3":"Socioeconomic Inequalities in the Non-Use of Dental Care in Europe"},{"title3":"Dental Care Coverage and Income-Related Inequalities in Foregone Dental Care in Europe during the Great Recession"},{"title3":"General Medicine and Surgery for Dental Practitioners: Part 4. Infections and Infection Control"},{"title3":"Trust in Dentist-Patient Relationships: Mapping the Relevant Concepts"},{"title3":"The Long-Term Effect of a Plaque Control Program on Tooth Mortality, Caries and Periodontal Disease in Adults. Results after 30 Years of Maintenance"},{"title3":"Sociobehavioural Risk Factors in Dental Caries:International Perspectives"},{"title3":"An Overview on Current Non-Invasive Diagnostic Devices in Oral Oncology"},{"title3":"Regular Dental Attendance and Periodontal Health Knowledge: A Cross-Sectional Survey"},{"title3":"Available Technologies, Applications and Benefits of Teleorthodontics. A Literature Review and Possible Applications during the COVID-19 Pandemic"},{"title3":"Social Research 2.0: Virtual Snowball Sampling Method Using Facebook"},{"title3":"Restaurant Brand Pages on Facebook: Do Active Member Participation and Monetary Sales Promotions Matter?"}]},{"title2":"Epidemiology and cause of severe acute respiratory syndrome (SARS) in Guangdong, People's Republic of China, in February, 2003","References":[{"title3":"Epidemiological study on severe acute respiratory syndrome in Guangdong province"},{"title3":"Guangdong Public Health Office. 2003: Document No 2. Summary report of investigating an atypical pneumonia outbreak in Zhongshan (January 21, 2003)."},{"title3":"A cluster of cases of severe acute respiratory syndrome in Hong Kong"},{"title3":"A major outbreak of severe acute respiratory syndrome in Hong Kong"},{"title3":"Update: outbreak of severe acute respiratory syndrome-Worldwide, 2003"},{"title3":"Severe acute respiratory syndrome (SARS)"},{"title3":"Cumulative number of reported probable cases of severe acute respiratory syndrome (SARS)"},{"title3":"Coronavirus as a possible cause of severe acute respiratory syndrome"},{"title3":"Identification of severe acute respiratory syndrome in Canada"},{"title3":"A novel coronavirus associated with severe acute respiratory syndrome"},{"title3":"Case definitions for surveillance of severe acute respiratory syndrome (SARS)"},{"title3":"The Genome sequence of the SARS-associated coronavirus"},{"title3":"Emergence of multiple genotypes of H5N1 avian influenza viruses in Hong Kong SAR"},{"title3":"MEGA2: molecular evolutionary genetics analysis software"},{"title3":"Quantitation of relative fitness and great adaptability of clonal populations of RNA viruses"},{"title3":"RNA virus mutations and fitness for survival"},{"title3":"A pandemic warning?"},{"title3":"Characterisation of an avian influenza A (H5N1) virus isolated from a child with a fatal respiratory illness"},{"title3":"An influenza epicentre?"}]},{"title2":"Severe acute respiratory syndrome","References":[]},{"title2":"Middle East respiratory syndrome","References":[]},{"title2":"Latest on the novel coronavirus outbreak","References":[{"title3":"The Middle East Respiratory Syndrome (MERS)"},{"title3":"Severe acute respiratory syndrome: historical, epidemiologic, and clinical features"},{"title3":"Pneumonia in China: lack of information raises concerns among Hong Kong health workers"},{"title3":"Taking forward a' One Health' approach for turning the tide against the Middle East respiratory syndrome coronavirus and other zoonotic pathogens with epidemic potential"},{"title3":"ProMED &quot;Novel coronavirus - China (01): (HU) WHO, phylogenetic tree&quot;. Archive Number: 20200112.6885385. Accessed 13 Jan 2020. https://www.ecohealthalliance.org/2020/01/phylogenetic-analysis-shows-novel-wuhan-coronavirus-clusters-with-sars."}]},{"title2":"Severe acute respiratory syndrome vs. the Middle East respiratory syndrome","References":[]},{"title2":"Response of memory CD8+ T cells to severe acute respiratory syndrome (SARS) coronavirus in recovered SARS patients and healthy individuals","References":[]},{"title2":"Predictors of mortality in Middle East respiratory syndrome (MERS)","References":[{"title3":"Middle East Respiratory Syndrome-Coronavirus (MERS-CoV): a case-controlstudy of hospitalized patients"},{"title3":"Predictors of MERS-CoV infection: a large case control study of patients presenting with ILI at a MERS-CoV referral hospital in Saudi Arabia"},{"title3":"A comparative study of clinical presentation and risk factors for adverse outcome in patients hospitalised with acute respiratory disease due to MERS coronavirus or other causes"},{"title3":"Differential Cell count and CRP level in Blood as predictors for Middle East respiratory syndrome coronavirus infection in acute febrile patients during nosocomial outbreak"},{"title3":"Managing MERS-CoV in the healthcare setting"},{"title3":"Hospital outbreak of Middle East respiratory syndrome coronavirus"},{"title3":"Epidemiological, demographic, and clinical characteristics of 47 cases of Middle East respiratory syndrome coronavirus disease from Saudi Arabia: a descriptive study"},{"title3":"High fatality rates and associated factors in two hospital outbreaks of MERS in Daejeon, the Republic of Korea"},{"title3":"A cohort-study of patients suspected for MERS-CoV in a referral hospital in Saudi Arabia"},{"title3":"Middle East respiratory syndrome coronavirus (MERS-CoV) outbreak in South Korea, 2015: epidemiology, characteristics and public health implications"},{"title3":"Clinical presentation and outcomes of Middle East respiratory syndrome in the Republic of Korea"},{"title3":"Clinical aspects and outcomes of 70 patients with Middle East respiratory syndrome coronavirus infection: a single-center experience in Saudi Arabia"},{"title3":"Imported cases of Middle East respiratory syndrome: an update"},{"title3":"Travel implications of emerging coronaviruses: SARS and MERS-CoV"},{"title3":"The characteristics of Middle eastern respiratory syndrome coronavirus transmission dynamics in South Korea"},{"title3":"Middle East respiratory syndrome coronavirus outbreak in the Republic of Korea"},{"title3":"Middle East respiratory syndrome coronavirus (MERS-CoV): prevention in travelers"},{"title3":"Systematic review of emerging respiratory viruses at the Hajj and possible coinfection with Streptococcus pneumoniae"},{"title3":"Asymptomatic Middle East Respiratory Syndrome Coronavirus (MERS-CoV) infection: extent and implications for infection control: a systematic review"},{"title3":"Epidemiology and predictors of survival of MERS-CoV infections in Riyadh region, 2014-2015"},{"title3":"Assays for laboratory confirmation of novel human coronavirus (hCoV-EMC) infections"},{"title3":"Influenza is more common than Middle East Respiratory Syndrome Coronavirus (MERS-CoV) among hospitalized adult Saudi patients"},{"title3":"Drivers of MERS-CoV transmission: what do we know?"},{"title3":"Middle East respiratory syndrome coronavirus: epidemiology and disease control measures"},{"title3":"Taking stock of the first 133 mers coronavirus cases globally-is the epidemic changing?"},{"title3":"State of knowledge and data gaps of Middle East respiratory syndrome coronavirus (MERS-CoV) in humans"},{"title3":"The predictors of 3- and 30-day mortality in 660 MERS-CoV patients"},{"title3":"Corticosteroid therapy for critically ill patients with Middle East respiratory syndrome"},{"title3":"Clinical aspects and outcomes of 70 patients with Middle East respiratory syndrome coronavirus infection: a single-center experience in Saudi Arabia"},{"title3":"Renal complications and their prognosis in Korean patients with Middle East respiratory syndrome-coronavirus from the central MERS-cov designated hospital"},{"title3":"Critically ill patients with the Middle East respiratory syndrome"},{"title3":"Extracorporeal membrane oxygenation for severe Middle East respiratory syndrome coronavirus"}]},{"title2":"Clinical and biochemical indexes from 2019-nCoV infected patients linked to viral loads and lung injury","References":[{"title3":"Clinical and immunological characteristics of human infections with H5N6 avian influenza virus"},{"title3":"A familial cluster of pneumonia associated with the 2019 novel coronavirus indicating person-to-person transmission: a study of a family cluster"},{"title3":"Angiotensin-converting enzyme 2 is an essential regulator of heart function"},{"title3":"Renal effects and associated outcomes during angiotensin-neprilysin inhibition in heart failure"},{"title3":"Angiotensin II signal transduction: an update on mechanisms of physiology and pathophysiology"},{"title3":"Long-term changes of renal function in relation to ace inhibitor/angiotensin receptor blocker dosing in patients with heart failure and chronic kidney disease"},{"title3":"The serum profile of hypercytokinemia factors identified in H7N9-infected patients can predict fatal outcomes"},{"title3":"Clinical features of patients infected with 2019 novel coronavirus in Wuhan, China"},{"title3":"Angiotensin II plasma levels are linked to disease severity and predict fatal outcomes in H7N9-infected patients"},{"title3":"Angiotensin-converting enzyme 2 protects from severe acute lung failure"},{"title3":"Characterization of cytokine/chemokine profiles of severe acute respiratory syndrome"},{"title3":"Predictive factors for pneumonia development and progression to respiratory failure in MERS-CoV infected patients"},{"title3":"A crucial role of angiotensin converting enzyme 2 (ACE2) in SARS coronavirus-induced lung injury"},{"title3":"Incidence and risk of chronic obstructive pulmonary disease in a Korean community-based cohort"},{"title3":"Early transmission dynamics in Wuhan, China, of novel coronavirus-infected pneumonia"},{"title3":"Effects of calcium channel blockers comparing to angiotensinconverting enzyme inhibitors and angiotensin receptor blockers in patients with hypertension and chronic kidney disease stage 3 to 5 and dialysis: A systematic review and meta-analysis"},{"title3":"Clinical and laboratory features of severe acute respiratory syndrome vis-a-vis onset of fever"},{"title3":"Population-based study of statins, angiotensin II receptor blockers, and angiotensin-converting enzyme inhibitors on pneumoniarelated outcomes"},{"title3":"An expanded definition of the adult respiratory distress syndrome"},{"title3":"A novel human mAb (MERS-GD27) provides prophylactic and postexposure efficacy in MERS-CoV susceptible mice"},{"title3":"Importance of endogenous compensatory vasoactive peptides in broadening the effects of inhibitors of the renin-angiotensin system for the treatment of heart failure"},{"title3":"Production of angiotensin I converting enzyme inhibitory (ACE-I) peptides during milk fermentation and their role in reducing hypertension"},{"title3":"A novel coronavirus genome identified in a cluster of pneumonia cases Wuhan, China 2019-2020"},{"title3":"Angiotensin blockade in late autosomal dominant polycystic kidney disease"},{"title3":"Hypoalbuminemia in acute illness: is there a rationale for intervention?"},{"title3":"Evolution of the novel coronavirus from the ongoing Wuhan outbreak and modeling of its spike protein for risk of human transmission"},{"title3":"Angiotensin II receptor blocker as a novel therapy in acute lung injury induced by avian influenza A H5N1 virus infection in mouse"},{"title3":"Comparison between human infections caused by highly and low pathogenic H7N9 avian influenza viruses in Wave Five: Clinical and virological findings"},{"title3":"A Novel Coronavirus from Patients with Pneumonia in China, 2019"},{"title3":"Angiotensin-converting enzyme 2 protects from lethal avian influenza A H5N1 infections"}]},{"title2":"Press conference of the State Council of the People's Republic of China","References":[]}]},{"title1":"30-day mortality in patients hospitalized with COVID-19 during the first wave of the Italian epidemic: A prospective cohort study","References":[{"title2":"Severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) and coronavirus disease-2019 (COVID-19): the epidemic and the challenges","References":[{"title3":"Outbreak of pneumonia of unknown etiology in Wuhan China: the mystery and the miracle"},{"title3":"Early transmission dynamics in Wuhan, China, of novel coronavirus-infected pneumonia"},{"title3":"Severe acute respiratory syndrome-related coronavirus: the species and its viruses:a statement of the Coronavirus Study Group"},{"title3":"Epidemiological and clinical characteristics of 99 cases of 2019 novel coronavirus pneumonia in Wuhan, China: a descriptive study"},{"title3":"Clinical features of patients infected with 2019 novel coronavirus in Wuhan, China"},{"title3":"A novel coronavirus outbreak of global health concern"},{"title3":"First case of 2019 novel coronavirus in the United States"},{"title3":"Clinical characteristics of 138 hospitalized patients with 2019 novel coronavirus-infected pneumonia in Wuhan, China"},{"title3":"Epidemiologic and clinical characteristics of novel coronavirus infections involving 13 patients outside Wuhan, China"},{"title3":"Novel Wuhan (2019-nCoV) coronavirus"},{"title3":"Preliminary estimation of the basic reproduction number of novel coronavirus (2019-nCoV) in China, from 2019 to 2020: a data-driven analysis in the early phase of the outbreak"},{"title3":"The next big threat to global health? 2019 novel coronavirus (2019-nCoV): What advice can we give to travellers? : Interim recommendations January 2020, from the Latin-American Society for Travel Medicine (SLAMVI)"},{"title3":"A novel coronavirus emerging in China:key questions for impact assessment"},{"title3":"The fight against the 2019-nCoV outbreak: an arduous march has just begun"},{"title3":"Characteristics of community-acquired respiratory viruses infections except seasonal influenza in transplant recipients and non-transplant critically ill patients"},{"title3":"Recommendations and guidelines for the treatment of pneumonia in Taiwan"},{"title3":"Community-acquired adenoviral and pneumococcal pneumonia complicated by pulmonary aspergillosis in an immunocompetent adult"},{"title3":"Severe community-acquired pneumonia due to Pseudomonas aeruginosa coinfection in an influenza A(H1N1)pdm09 patient"},{"title3":"Performance of a multiplex PCR pneumonia panel for the identification of respiratory pathogens and the main determinants of resistance from the lower respiratory tract specimens of adult patients in intensive care units"},{"title3":"Molecular epidemiology and clinical features of rhinovirus infections among hospitalized patients in a medical center in Taiwan"},{"title3":"Molecular epidemiology and clinical features of adenovirus infection in Taiwanese children, 2014"},{"title3":"Genomic characterization of the 2019 novel human-pathogenic coronavirus isolated from a patient with atypical pneumonia after visiting Wuhan"},{"title3":"Genomic characterisation and epidemiology of 2019 novel coronavirus: implications for virus origins and receptor binding"},{"title3":"A novel coronavirus from patients with pneumonia in China, 2019"},{"title3":"An emerging coronavirus causing pneumonia outbreak in Wuhan, China: calling for developing therapeutic and prophylactic strategies"},{"title3":"Identification of a novel coronavirus causing severe pneumonia in human: a descriptive study"},{"title3":"RNA based mNGS approach identifies a novel human coronavirus from two individual pneumonia cases in 2019 Wuhan outbreak"},{"title3":"A pneumonia outbreak associated with a new coronavirus of probable bat origin"},{"title3":"Nowcasting and forecasting the potential domestic and international spread of the 2019-nCoV outbreak originating in Wuhan, China: a modelling study"},{"title3":"Incubation period of 2019 novel coronavirus (2019-nCoV) infections among travelers from Wuhan, China, 20-28 January 2020"},{"title3":"Diagnosis and treatment recommendations for pediatric respiratory infection caused by the 2019 novel coronavirus"},{"title3":"Epidemiological characteristics of 2019 novel coronavirus: an interim review"},{"title3":"CT imaging features of 2019 novel coronavirus (2019-nCoV)"},{"title3":"Chest CT findings in 2019 novel coronavirus (2019-nCoV) infections from Wuhan, China: key points for the radiologist"},{"title3":"Emerging coronavirus 2019-nCoV pneumonia"},{"title3":"Drug treatment options for the 2019-new coronavirus (2019-nCoV)"},{"title3":"Remdesivir and chloroquine effectively inhibit the recently emerged novel coronavirus (2019-nCoV) in vitro"},{"title3":"Learning from the past: possible urgent prevention and treatment options for severe acute respiratory infections caused by 2019-nCoV"},{"title3":"Recycling of chloroquine and its hydroxyl analogue to face bacterial, fungal and viral infections in the 21st century"},{"title3":"Updated understanding of the outbreak of 2019 novel coronavirus (2019-nCoV) in Wuhan, China"},{"title3":"The first case of 2019 novel coronavirus pneumonia imported into Korea from Wuhan, China: implication for infection prevention and control measures"},{"title3":"World Health Organization (WHO). Novel coronavirus (2019-nCoV). Situation report. https://www.who.int/docs/default-source/coronaviruse/situation-reports/20200207-sitrep-18-ncov.pdf?sfvrsn=fa644293_2[accessed 9 February 2020]."},{"title3":"Initial public health response and interim clinical guidance for the 2019 novel coronavirus outbreak:United States, December 31, 2019-February 4, 2020"},{"title3":"Effects of air temperature and relative humidity on coronavirus survival on surfaces"},{"title3":"Persistence of coronaviruses on inanimate surfaces and its inactivation with biocidal agents"},{"title3":"Clinical characteristics of 2019 novel coronavirus infection in China"},{"title3":"Coronavirus infections and immune responses"},{"title3":"Clinical evidence does not support corticosteroid treatment for 2019-nCoV lung injury"}]},{"title2":"Clinical features of patients infected with 2019 novel coronavirus in Wuhan, China","References":[{"title3":"A familial cluster of pneumonia associated with the 2019 novel coronavirus indicating person-to-person transmission: a study of a family cluster"},{"title3":"A familial cluster of pneumonia associated with the 2019 novel coronavirus indicating person-to-person transmission: a study of a family cluster"},{"title3":"Epidemiological and clinical characteristics of 99 cases of 2019 novel coronavirus pneumonia in Wuhan, China: adescriptivestudy"},{"title3":"Epidemiological and clinical characteristics of 99 cases of 2019 novel coronavirus pneumonia in Wuhan, China: a descriptive study"},{"title3":"First case of 2019 novel coronavirus in the United States"},{"title3":"Clinical features of patients infected with 2019 novel coronavirus in Wuhan, China"},{"title3":"Lung CT image of a confirmed case of the 2019 novel coronavirus (2019-nCoV) infected pneumonia (With differential diagnosis of the SARS)"},{"title3":"Early transmission dynamics in Wuhan, China, of novel coronavirus-infected pneumonia"},{"title3":"Role of neutrophil to lymphocyte and monocyte to lymphocyte ratios in the diagnosis of bacterial infection in patients with fever"},{"title3":"Coronavirus infections-more than just the common cold"},{"title3":"The association between the neutrophil-to-lymphocyte ratio and mortality in critical illness: an observational cohort study"},{"title3":"A new coronavirus associated with human respiratory disease in China"},{"title3":"Monocyte/lymphocyte ratio as a better predictor of cardiovascular and all-cause mortality in hemodialysis patients: a prospective cohort study"},{"title3":"Ratio of neutrophil to lymphocyte counts-rapid and simple parameter of systemic inflammation and stress in critically ill"},{"title3":"Neutrophil-lymphocyte ratio as an early new marker in AIV-H7N9-infected patients: a retrospective study"}]},{"title2":"A novel coronavirus from patients with pneumonia in China, 2019. China novel coronavirus investigating and research team","References":[]},{"title2":"Clinical characteristics of 138 hospitalized patients with 2019 novel coronavirus-infected pneumonia in Wuhan, China","References":[]},{"title2":"Characteristics of and important lessons from the coronavirus disease 2019 (COVID-19) outbreak in China: summary of a report of 72 314 cases from the Chinese Center for Disease Control and Prevention","References":[]},{"title2":"https://www.epicentro.iss.it/coronavirus/bollettino/Infografica_27aprile%20ITA.pdfAccessed April 27, 2020.","References":[]},{"title2":"https://www.epicentro.iss.it/coronavirus/sars-cov-2-dpcm-1-marzo-2020 Accessed April 27, 2020.","References":[]},{"title2":"https://www.who.int/topics/obesity/en/ Accessed 20 April, 2020.","References":[]},{"title2":"New method of classifying prognostic comorbidity in longitudinal studies: development and validation","References":[]},{"title2":"Clinical characteristics of imported cases of COVID-19 in Jiangsu Province: a multicenter descriptive study","References":[]},{"title2":"Risk factors associated with acute respiratory distress syndrome and death in patients with coronavirus disease 2019 pneumonia in Wuhan, China [published online ahead of print, 2020 Mar 13]","References":[]},{"title2":"Real-time tentative assessment of the epidemiological characteristics of novel coronavirus infections in Wuhan, China, as at 22 January 2020","References":[{"title3":"Epidemiology, Genetic Recombination, and Pathogenesis of Coronaviruses."},{"title3":"Bat Coronaviruses in China."},{"title3":"Epidemic and Emerging Coronaviruses (Severe Acute Respiratory Syndrome and Middle East Respiratory Syndrome)."},{"title3":"Molecular epidemiology of the novel coronavirus that causes severe acute respiratory syndrome."},{"title3":"World Health Organization Regional Office for the (WHO/Eastern Mediterranean). MERS Situation Update. Cairo: WHO/Eastern Mediterranean; Nov2019. [Accessed 11 Jan 2020]. Available from: http://applications.emro.who.int/docs/EMRPUB-CSR-241-2019-EN.pdf?ua=1&amp;ua=1 "},{"title3":"Preliminary epidemiological assessment of MERS-CoV outbreak in South Korea, May to June 2015."},{"title3":"Middle East respiratory syndrome coronavirus (MERS-CoV) outbreak in South Korea, 2015: epidemiology, characteristics and public health implications."},{"title3":"MERS, SARS, and Ebola: The Role of Super-Spreaders in Infectious Disease."},{"title3":"The role of superspreading in Middle East respiratory syndrome coronavirus (MERS-CoV) transmission."},{"title3":"Unusual presentation of Middle East respiratory syndrome coronavirus leading to a large outbreak in Riyadh during 2017."},{"title3":"World Health Organization (WHO). WHO Statement Regarding Cluster of Pneumonia Cases in Wuhan, China. Beijing: WHO; 9 Jan 2020. [Accessed 11 Jan 2020]. https://www.who.int/china/news/detail/09-01-2020-who-statement-regarding-cluster-of-pneumonia-cases-in-wuhan-china "},{"title3":"Wuhan Municipal Health Commission. [Update on outbreak of pneumonia cases in Wuhan]. 31 Dec 2019. [Accessed 13 Jan 2020]. Chinese. Available from: http://wjw.wuhan.gov.cn/front/web/showDetail/2019123108989 "},{"title3":"Beijing News. [Southern China Seafood Market linked to unexplained pneumonia outbreak]. 2 Jan 2020. [Accessed 13 Jan 2020]. Chinese. Available from: http://epaper.bjnews.com.cn/html/2020-01/02/content_775695.htm "},{"title3":"Wuhan Municipal Health Commission. [Report on unexplained viral pneumonia]. 5 Jan 2020. [Accessed 21 Jan 2020]. Chinese. Available from: http://wjw.wuhan.gov.cn/front/web/showDetail/2020010509020 "},{"title3":"Wuhan Municipal Health Commission. [Report on unexplained viral pneumonia]. 11 Jan 2020. [Accessed 21 Jan 2020]. Chinese. Available from: http://wjw.wuhan.gov.cn/front/web/showDetail/2020011109035 "},{"title3":"Cheung J. Ill husband and wife add to Wuhan riddle. Hong Kong; The Standard; 16 Jan 2020. [Accessed 20 Jan 2020]. Available from: https://www.thestandard.com.hk/sections-news-print/215457/Ill-husband-and-wife--add-to-Wuhan-riddle "},{"title3":"Using routine surveillance data to estimate the epidemic potential of emerging zoonoses: application to the emergence of US swine origin influenza A H3N2v virus."},{"title3":"Wuhan Municipal Health Commission. [Questions and answers on pneumonia due to novel coronavirus infection]. 14 Jan 2020. [Accessed 20 Jan 2020]. Chinese. Available from: http://wjw.wuhan.gov.cn/front/web/showDetail/2020011509040 "},{"title3":"Transmission scenarios for Middle East Respiratory Syndrome Coronavirus (MERS-CoV) and how to tell them apart."},{"title3":"World Health Organization Regional Office for the Western Pacific (WHO/Pacific). World Health Organization Western Pacific Twitter Feed. Manila: WHO/Pacific; 8:35 PM 20 Jan 2020. Available from: https://twitter.com/WHOWPRO "},{"title3":"Human infection with avian influenza A H7N9 virus: an assessment of clinical severity."},{"title3":"Methods for estimating the case fatality ratio for a novel, emerging infectious disease."},{"title3":"Clinical prognostic rules for severe acute respiratory syndrome in low- and high-resource settings."},{"title3":"A comparative epidemiologic analysis of SARS in Hong Kong, Beijing and Taiwan."},{"title3":"Middle East respiratory syndrome coronavirus: risk factors and determinants of primary, household, and nosocomial transmission."},{"title3":"The epidemiology of severe acute respiratory syndrome in the 2003 Hong Kong epidemic: an analysis of all 1755 patients."},{"title3":"Non-parametric estimation of the case fatality ratio with competing risks data: an application to Severe Acute Respiratory Syndrome (SARS)."},{"title3":"Chinese National Health Commission (NHC). [Experts answer reporters' questions on pneumonia outbreak of new coronavirus infection]. Beijing: NHC; 20 Jan 2020. [Accessed 20 Jan 2020]. Chinese http://www.nhc.gov.cn/xcs/s7847/202001/8d735f0bb50b45af928d9944d16950c8.shtml "},{"title3":"Chinese National Health Commission (NHC). [Press conference in response to the outbreak of pneumonia caused by 2019-nCoV]. Beijing: NHC; 21 Jan 2020. [Accessed 21 Jan 2020]. Chinese. Available from: http://www.nhc.gov.cn/xcs/s7847/202001/8d735f0bb50b45af928d9944d16950c8.shtml "},{"title3":"World Health Organization (WHO). Novel Coronavirus - Thailand (ex-China). Geneva: WHO: 14 Jan 2020. Available from: https://www.who.int/csr/don/14-january-2020-novel-coronavirus-thailand/en/ "},{"title3":"World Health Organization (WHO). Novel Coronavirus - Japan (ex-China). Geneva: WHO; 16 Jan 2020. Available from: https://www.who.int/csr/don/16-january-2020-novel-coronavirus-japan-ex-china/en/ "},{"title3":"Centers for Disease Control and Prevention (CDC). First Travel-related Case of 2019 Novel Coronavirus Detected in United States. Atlanta: CDC; 21 Jan 2020. Available from: https://www.cdc.gov/media/releases/2020/p0121-novel-coronavirus-travel-case.html "},{"title3":"Taiwan Centers for Disease Control (CDC). Taiwan timely identifies first imported case of severe special infectious pneumonia from Wuhan, China through onboard quarantine; Central Epidemic Command Center (CECC) raises travel notice level for Wuhan, China to Level 3: Warning. Taipei City: CDC; 21 Jan 2020. Available from: https://www.cdc.gov.tw/En/Bulletin/Detail/pVg_jRVvtHhp94C6GShRkQ?typeid=158 "}]},{"title2":"Clinical course and risk factors for mortality of adult inpatients with COVID-19 in Wuhan, China: a retrospective cohort study [published correction appears in Lancet. 2020 Mar 28;395(10229):1038] [published correction appears in Lancet. 2020 Mar 28;395(10229):1038]","References":[{"title3":"The novel coronavirus originating in Wuhan, China: challenges for global health governance"},{"title3":"Severe acute respiratory syndrome-related coronavirus: the species and its viruses:a statement of the Coronavirus Study Group"},{"title3":"Short term outcome and risk factors for adverse clinical outcomes in adults with severe acute respiratory syndrome (SARS)"},{"title3":"Early transmission dynamics in Wuhan, China, of novel coronavirus-infected pneumonia"},{"title3":"Clinical features of patients infected with 2019 novel coronavirus in Wuhan, China"},{"title3":"Clinical characteristics of 138 hospitalized patients with 2019 novel coronavirus-infected pneumonia in Wuhan, China"},{"title3":"Epidemiological and clinical characteristics of 99 cases of 2019 novel coronavirus pneumonia in Wuhan, China: a descriptive study"},{"title3":"Management of adults with hospital-acquired and ventilator-associated pneumonia: 2016 clinical practice guidelines by the Infectious Diseases Society of America and the American Thoracic Society"},{"title3":"KDIGO clinical practice guidelines for acute kidney injury"},{"title3":"Acute respiratory distress syndrome: the Berlin Definition"},{"title3":"Chinese management guideline for COVID-19 (version 6.0)"},{"title3":"Clinical course and outcomes of critically ill patients with SARS-CoV-2 pneumonia in Wuhan, China: a single-centered, retrospective, observational study"},{"title3":"Middle East respiratory syndrome"},{"title3":"Outcomes and prognostic factors in 267 patients with severe acute respiratory syndrome in Hong Kong"},{"title3":"Predictors of mortality in Middle East respiratory syndrome (MERS)"},{"title3":"Exacerbated innate host response to SARS-CoV in aged non-human primates"},{"title3":"The immunopathogenesis of sepsis in elderly patients"},{"title3":"The Third International Consensus Definitions for Sepsis and Septic Shock (Sepsis-3)"},{"title3":"Serial evaluation of the SOFA score to predict outcome in critically ill patients"},{"title3":"Disease severity and clinical outcomes of community-acquired pneumonia caused by non-influenza respiratory viruses in adults: a multicentre prospective registry study from the CAP-China Network"},{"title3":"Community-acquired pneumonia requiring admission to an intensive care unit: a descriptive study"},{"title3":"Acute pneumonia and the cardiovascular system"},{"title3":"Association between influenza vaccination and cardiovascular outcomes in high-risk patients: a meta-analysis"},{"title3":"Laboratory-confirmed respiratory infections as predictors of hospital admission for myocardial infarction and stroke: time-series analysis of English data for 2004-2015"},{"title3":"Prevalence and significance of coagulation abnormalities in community-acquired pneumonia"},{"title3":"D-dimer is a significant prognostic factor in patients with suspected infection and sepsis"},{"title3":"Risk of myocardial infarction and stroke after acute infection or vaccination"},{"title3":"Cardiac complications in patients with community-acquired pneumonia: incidence, timing, risk factors, and association with short-term mortality"},{"title3":"Cardiovascular complications of acute respiratory infections: current research and future directions"},{"title3":"Regulation of ACE2 in cardiac myocytes and fibroblasts"},{"title3":"ACE2 and vasoactive peptides: novel players in cardiovascular/renal remodeling and hypertension"},{"title3":"Pathological findings of COVID-19 associated with acute respiratory distress syndrome"},{"title3":"Persistent shedding of viable SARS-CoV in urine and stool of SARS patients during the convalescent phase"},{"title3":"Viral shedding and antibody response in 37 patients with Middle East Respiratory Syndrome coronavirus infection"},{"title3":"Viral load kinetics of MERS coronavirus infection"},{"title3":"Factors associated with prolonged viral shedding in patients with avian influenza A(H7N9) virus infection"},{"title3":"SARS-CoV-2 viral load in upper respiratory specimens of infected patients"}]},{"title2":"Gender and COVID-19 Working Group. COVID-19: the gendered impacts of the outbreak [published online ahead of print, 2020 Mar 6]","References":[]},{"title2":"Kidney disease is associated with in-hospital death of patients with COVID-19 [published online ahead of print, 2020 Mar 20]","References":[]},{"title2":"https://www.ecdc.europa.eu/en/current-risk-assessment-novel-coronavirus-situation Accessed April 20, 2020.","References":[]},{"title2":"Presenting characteristics, comorbidities, and outcomes among 5700 patients hospitalized with COVID-19 in the New York City area [published online ahead of print, 2020 Apr 22]","References":[]},{"title2":"Clinical characteristics of coronavirus disease 2019 in China [published online ahead of print, 2020 Feb 28]","References":[{"title3":"Early transmission dynamics in Wuhan, China, of novel coronavirus-infected pneumonia."},{"title3":"Challenges in laboratory diagnosis of the novel coronavirus SARS-CoV-2."},{"title3":"Clinical features of patients infected with 2019 novel coronavirus in Wuhan, China."},{"title3":"First case of 2019 novel Coronavirus in the United States."},{"title3":"Epidemiological and clinical characteristics of 99 cases of 2019 novel coronavirus pneumonia in Wuhan, China: a descriptive study."},{"title3":"A novel coronavirus associated with severe acute respiratory syndrome."},{"title3":"A preventive and control strategy for COVID-19 infection: an experience from a Third-Tier Chinese City."},{"title3":"An emerging coronavirus causing pneumonia outbreak in Wuhan, China: calling for developing therapeutic and prophylactic strategies."},{"title3":"Measures for diagnosing and treating infections by a novel coronavirus responsible for a pneumonia outbreak originating in Wuhan, China."},{"title3":"Perspectives on therapeutic neutralizing antibodies against the Novel Coronavirus SARS-CoV-2."},{"title3":"COVID-19, an emerging coronavirus infection: advances and prospects in designing and developing vaccines, immunotherapeutics, and therapeutics."},{"title3":"Transplantation of ACE2(-) mesenchymal stem cells improves the outcome of patients with COVID-19 pneumonia."},{"title3":"On the use of corticosteroids for 2019-nCoV pneumonia."},{"title3":"Comprehensive analysis of drugs to treat SARSCoV2 infection: mechanistic insights into current COVID19 therapies (Review)."},{"title3":"The role of telemedicine during the COVID-19 epidemic in China-experience from Shandong province."},{"title3":"Human umbilical cord-derived mesenchymal stem cell therapy in patients with COVID-19: a phase 1 clinical trial."},{"title3":"Intravenous infusion of human umbilical cord Wharton's jelly-derived mesenchymal stem cells as a potential treatment for patients with COVID-19 pneumonia."},{"title3":"Flattening the COVID-19 curve with natural killer cell based immunotherapies."},{"title3":"A familial cluster of pneumonia associated with the 2019 novel coronavirus indicating person-to-person transmission: a study of a family cluster."},{"title3":"Full-genome evolutionary analysis of the novel corona virus (2019-nCoV) rejects the hypothesis of emergence as a result of a recent recombination event."},{"title3":"Epidemiologic and clinical characteristics of novel coronavirus infections involving 13 patients outside Wuhan, China."},{"title3":"Spatio-temporal metabolokinetics and efficacy of human placenta-derived mesenchymal stem/stromal cells on mice with refractory Crohn's-like enterocutaneous fistula."},{"title3":"High-efficient generation of VCAM-1(+) mesenchymal stem cells with multidimensional superiorities in signatures and efficacy on aplastic anaemia mice."},{"title3":"Systematic comparison of hUC-MSCs at various passages reveals the variations of signatures and therapeutic effect on acute graft-versus-host disease."},{"title3":"JNKi- and DAC-programmed mesenchymal stem/stromal cells from hESCs facilitate hematopoiesis and alleviate hind limb ischemia."},{"title3":"Identification of a novel coronavirus in patients with severe acute respiratory syndrome."},{"title3":"Studies on viral pneumonia related to novel coronavirus SARS-CoV-2, SARS-CoV, and MERS-CoV: a literature review."},{"title3":"Three emerging coronaviruses in two decades."},{"title3":"The epidemic of 2019-novel-coronavirus (2019-nCoV) pneumonia and insights for emerging infectious diseases in the future."},{"title3":"Coronaviruses - drug discovery and therapeutic options."},{"title3":"The pathogenicity of SARS-CoV-2 in hACE2 transgenic mice."},{"title3":"Acute respiratory distress syndrome: the Berlin Definition."},{"title3":"Pediatric acute respiratory distress syndrome: definition, incidence, and epidemiology: proceedings from the Pediatric Acute Lung Injury Consensus Conference."},{"title3":"Eicosanoid storm in infection and inflammation."},{"title3":"Decoding the enigma of antiviral crisis: does one target molecule regulate all?"}]},{"title2":"Analysis of epidemiological and clinical features in older patients with corona virus disease 2019 (COVID-19) out of Wuhan","References":[]},{"title2":"Outcomes and prognostic factors in 267 patients with severe acute respiratory syndrome in Hong Kong","References":[]},{"title2":"Predictors of mortality in Middle East respiratory syndrome (MERS)","References":[{"title3":"Middle East Respiratory Syndrome-Coronavirus (MERS-CoV): a case-controlstudy of hospitalized patients"},{"title3":"Predictors of MERS-CoV infection: a large case control study of patients presenting with ILI at a MERS-CoV referral hospital in Saudi Arabia"},{"title3":"A comparative study of clinical presentation and risk factors for adverse outcome in patients hospitalised with acute respiratory disease due to MERS coronavirus or other causes"},{"title3":"Differential Cell count and CRP level in Blood as predictors for Middle East respiratory syndrome coronavirus infection in acute febrile patients during nosocomial outbreak"},{"title3":"Managing MERS-CoV in the healthcare setting"},{"title3":"Hospital outbreak of Middle East respiratory syndrome coronavirus"},{"title3":"Epidemiological, demographic, and clinical characteristics of 47 cases of Middle East respiratory syndrome coronavirus disease from Saudi Arabia: a descriptive study"},{"title3":"High fatality rates and associated factors in two hospital outbreaks of MERS in Daejeon, the Republic of Korea"},{"title3":"A cohort-study of patients suspected for MERS-CoV in a referral hospital in Saudi Arabia"},{"title3":"Middle East respiratory syndrome coronavirus (MERS-CoV) outbreak in South Korea, 2015: epidemiology, characteristics and public health implications"},{"title3":"Clinical presentation and outcomes of Middle East respiratory syndrome in the Republic of Korea"},{"title3":"Clinical aspects and outcomes of 70 patients with Middle East respiratory syndrome coronavirus infection: a single-center experience in Saudi Arabia"},{"title3":"Imported cases of Middle East respiratory syndrome: an update"},{"title3":"Travel implications of emerging coronaviruses: SARS and MERS-CoV"},{"title3":"The characteristics of Middle eastern respiratory syndrome coronavirus transmission dynamics in South Korea"},{"title3":"Middle East respiratory syndrome coronavirus outbreak in the Republic of Korea"},{"title3":"Middle East respiratory syndrome coronavirus (MERS-CoV): prevention in travelers"},{"title3":"Systematic review of emerging respiratory viruses at the Hajj and possible coinfection with Streptococcus pneumoniae"},{"title3":"Asymptomatic Middle East Respiratory Syndrome Coronavirus (MERS-CoV) infection: extent and implications for infection control: a systematic review"},{"title3":"Epidemiology and predictors of survival of MERS-CoV infections in Riyadh region, 2014-2015"},{"title3":"Assays for laboratory confirmation of novel human coronavirus (hCoV-EMC) infections"},{"title3":"Influenza is more common than Middle East Respiratory Syndrome Coronavirus (MERS-CoV) among hospitalized adult Saudi patients"},{"title3":"Drivers of MERS-CoV transmission: what do we know?"},{"title3":"Middle East respiratory syndrome coronavirus: epidemiology and disease control measures"},{"title3":"Taking stock of the first 133 mers coronavirus cases globally-is the epidemic changing?"},{"title3":"State of knowledge and data gaps of Middle East respiratory syndrome coronavirus (MERS-CoV) in humans"},{"title3":"The predictors of 3- and 30-day mortality in 660 MERS-CoV patients"},{"title3":"Corticosteroid therapy for critically ill patients with Middle East respiratory syndrome"},{"title3":"Clinical aspects and outcomes of 70 patients with Middle East respiratory syndrome coronavirus infection: a single-center experience in Saudi Arabia"},{"title3":"Renal complications and their prognosis in Korean patients with Middle East respiratory syndrome-coronavirus from the central MERS-cov designated hospital"},{"title3":"Critically ill patients with the Middle East respiratory syndrome"},{"title3":"Extracorporeal membrane oxygenation for severe Middle East respiratory syndrome coronavirus"}]},{"title2":"Obesity in patients younger than 60 years is a risk factor for Covid-19 hospital admission [published online ahead of print, 2020 Apr 9]","References":[]},{"title2":"High prevalence of obesity in severe acute respiratory syndrome coronavirus-2 (SARS-CoV-2) requiring invasive mechanical ventilation [published online ahead of print, 2020 Apr 9]","References":[]},{"title2":"Obesity a risk factor for severe COVID-19 infection: multiple potential mechanisms [published online ahead of print, 2020 Apr 22]","References":[]},{"title2":"Prognostic value of C-reactive protein in patients with COVID-19","References":[]},{"title2":"C-reactive protein: ligands, receptors and role in inflammation","References":[]},{"title2":"Increased serum creatine phosphokinase activity in experimental pulmonary embolism","References":[]}]},{"title1":"Clinical characteristics of 113 deceased patients with coronavirus disease 2019: retrospective study","References":[{"title2":"Identification of a novel coronavirus in patients with severe acute respiratory syndrome","References":[]},{"title2":"Isolation of a novel coronavirus from a man with pneumonia in Saudi Arabia","References":[]},{"title2":"A Novel Coronavirus from Patients with Pneumonia in China, 2019","References":[{"title3":"Clinical features of patients infected with 2019 novel coronavirus in Wuhan, China"},{"title3":"A familial cluster of pneumonia associated with the 2019 novel coronavirus indicating person-to-person transmission: a study of a family cluster"},{"title3":"Epidemiological and clinical characteristics of 99 cases of 2019 novel coronavirus pneumonia in Wuhan, China: a descriptive study"},{"title3":"A novel coronavirus from patients with pneumonia in China, 2019"},{"title3":"Inferring the hosts of coronavirus using dual statistical models based on nucleotide composition"},{"title3":"Importation and human-to-human transmission of a novel coronavirus in Vietnam"},{"title3":"2019 novel coronavirus (2019-nCoV) outbreak: a new challenge"},{"title3":"Clinical Characteristics of 138 Hospitalized Patients With 2019 Novel Coronavirus-Infected Pneumonia in Wuhan"},{"title3":"Identification of a novel coronavirus causing severe pneumonia in human: a descriptive study"},{"title3":"A new coronavirus associated with human respiratory disease in China"},{"title3":"Measures for diagnosing and treating infections by a novel coronavirus responsible for a pneumonia outbreak originating in Wuhan, China"},{"title3":"Novel Wuhan (2019-nCoV) coronavirus"},{"title3":"Severe acute respiratory syndrome coronavirus phylogeny: toward consensus"},{"title3":"Diagnosis and treatment of new coronavirus pneumonia (trial version 7) [J / OL]. Tianjin J Tradit Chin Med. 2020;1-5. http://kns.cnki.net/kcms/detail/12.1349.R.20200304.1638.006.html. Accessed 3 June 2020."},{"title3":"Clinical outcome of standardized oxygen therapy nursing strategy in COVID-19"},{"title3":"Radiological findings from 81 patients with COVID-19 pneumonia in Wuhan, China: a descriptive study"},{"title3":"Evolution of the novel coronavirus from the ongoing Wuhan outbreak and modeling of its spike protein for risk of human transmission"},{"title3":"Angiotensin-converting enzyme 2: a functional receptor for SARS coronavirus"},{"title3":"Single-cell RNA-seq data analysis on the receptor ACE2 expression reveals the potential risk of different human organs vulnerable to 2019-nCoV infection"},{"title3":"High expression of ACE2 receptor of 2019-nCoV on the epithelial cells of oral mucosa"},{"title3":"Tissue distribution of ACE2 protein, the functional receptor for SARS coronavirus. A first step in understanding SARS pathogenesis"},{"title3":"Cryo-EM structure of the 2019-nCoV spike in the prefusion conformation"},{"title3":"Organ distribution of severe acute respiratory syndrome (SARS) associated coronavirus (SARS-CoV) in SARS patients: implications for pathogenesis and virus transmission pathways"},{"title3":"Significant changes of peripheral T lymphocyte subsets in patients with severe acute respiratory syndrome"},{"title3":"Overlapping and discrete aspects of the pathology and pathogenesis of the emerging human pathogenic coronaviruses SARS-CoV, MERS-CoV, and 2019-nCoV"},{"title3":"Lactate dehydrogenase and C-reactive protein as predictors of respiratory failure in CoVID-19 patients"},{"title3":"Lactate dehydrogenase, an independent risk factor of severe COVID-19 patients: a retrospective and observational study"},{"title3":"C-reactive protein correlates with computed tomographic findings and predicts severe COVID-19 early"},{"title3":"Eosinopenia and elevated C-reactive protein facilitate triage of COVID-19 patients in fever clinic: a retrospective case-control study"},{"title3":"Association of cardiac injury with mortality in hospitalized patients with COVID-19 in Wuhan, China"},{"title3":"Cardiovascular implications of fatal outcomes of patients with coronavirus disease 2019 (COVID-19)"},{"title3":"Clinical course and risk factors for mortality of adult inpatients with COVID-19 in Wuhan, China: a retrospective cohort study"},{"title3":"Human ipsc-derived cardiomyocytes are susceptible to Sars-Cov-2 infection"},{"title3":"Cardiovascular complications in COVID-19"},{"title3":"COVID-19 pandemic and troponin: indirect myocardial injury, myocardial inflammation or myocarditis?"},{"title3":"Endothelial cell infection and endotheliitis in COVID-19"}]},{"title2":"Return of the Coronavirus: 2019-nCoV","References":[{"title3":"Wuhan Municipal Health and Health Commission's Briefing on the Current Pneumonia Epidemic Situation in Our City"},{"title3":"New Virus Discovered by Chinese Scientists Investigating Pneumonia Outbreak"},{"title3":"WHO Statement Regarding Cluster of Pneumonia Cases in Wuhan, China"},{"title3":"Novel 2019 Coronavirus Genome"},{"title3":"2020 Coronavirus"},{"title3":"Novel Coronavirus:Japan (ex-China)"},{"title3":"Laboratory Testing for 2019 Novel Coronavirus (2019-nCoV) in Suspected Human Cases"},{"title3":"Estimating the Potential Total Number of Novel Coronavirus (2019-nCoV) Cases in Wuhan City, China"},{"title3":"Wuhan Municipal Commission of Health and Health on Pneumonia of New Coronavirus Infection"},{"title3":"Super-spreaders in infectious diseases"},{"title3":"Wuhan Virus: China Locks down Huanggang, Shuts Down Railway Station in Ezhou after Wuhan Lockdown"},{"title3":"Homologous recombination within the spike glycoprotein of the newly identified coronavirus may boost cross-species transmission from snake to human"},{"title3":"nCoV's Relationship to Bat Coronaviruses and Recombination Signals No Snakes"},{"title3":"Molecular evolution analysis and geographic investigation of severe acute respiratory syndrome coronavirus-like virus in palm civets at an animal market and on farms"},{"title3":"Severe acute respiratory syndrome coronavirus-like virus in Chinese horseshoe bats"},{"title3":"A SARS-like cluster of circulating bat coronaviruses shows potential for human emergence"},{"title3":"SARS-like WIV1-CoV poised for human emergence"},{"title3":"Serological Evidence of Bat SARS-Related Coronavirus Infection in Humans, China"},{"title3":"Further Evidence for Bats as the Evolutionary Source of Middle East Respiratory Syndrome Coronavirus"},{"title3":"Identification of a severe acute respiratory syndrome coronavirus-like virus in a leaf-nosed bat in Nigeria"},{"title3":"Evidence for camel-to-human transmission of MERS coronavirus"},{"title3":"Middle East Respiratory Syndrome: Emergence of a Pathogenic Human Coronavirus"},{"title3":"Viral Loads in Clinical Specimens and SARS Manifestations"},{"title3":"Epidemiological, demographic, and clinical characteristics of 47 cases of Middle East respiratory syndrome coronavirus disease from Saudi Arabia: A descriptive study"},{"title3":"Risk Factors for Fatal Middle East Respiratory Syndrome Coronavirus Infections in Saudi Arabia: Analysis of the WHO Line List, 2013-2018"},{"title3":"SARS Severe Acute Respiratory Syndrome"},{"title3":"MERS-CoV"},{"title3":"Preliminary Phylogenetic Analysis of 11 nCoV2019 Genomes, 2020-01-19"},{"title3":"Genomic Epidemiology of Novel Coronavirus (nCoV) Using Data Generated by Fudan University, China CDC, Chinese Academy of Medical Sciences, Chinese Academy of Sciences and the Thai National Institute of Health Shared via GISAID"},{"title3":"Discovery of a novel coronavirus associated with the recent pneumonia outbreak in humans and its potential bat origin"},{"title3":"Jumping species-a mechanism for coronavirus persistence and survival"},{"title3":"Synthetic recombinant bat SARS-like coronavirus is infectious in cultured cells and in mice"},{"title3":"The S proteins of human coronavirus NL63 and severe acute respiratory syndrome coronavirus bind overlapping regions of ACE2"},{"title3":"Bat Severe Acute Respiratory Syndrome-Like Coronavirus WIV1 Encodes an Extra Accessory Protein, ORFX, Involved in Modulation of the Host Immune Response"},{"title3":"Evolution of the novel coronavirus from the ongoing Wuhan outbreak and modeling of its spike protein for risk of human transmission"},{"title3":"Functional assessment of cell entry and receptor usage for lineage B beta-coronaviruses, including 2019-nCoV"},{"title3":"Viruses and Koch's Postulates"},{"title3":"A mouse-adapted SARS-coronavirus causes disease and mortality in BALB/c mice"},{"title3":"Replication of SARS coronavirus administered into the respiratory tract of African Green, rhesus and cynomolgus monkeys"},{"title3":"Newly discovered coronavirus as the primary cause of severe acute respiratory syndrome"},{"title3":"Host species restriction of Middle East respiratory syndrome coronavirus through its receptor, dipeptidyl peptidase 4"},{"title3":"Mouse dipeptidyl peptidase 4 is not a functional receptor for Middle East respiratory syndrome coronavirus infection"},{"title3":"Middle East respiratory syndrome coronavirus (MERS-CoV) causes transient lower respiratory tract infection in rhesus macaques"},{"title3":"15 Medical Staff in Wuhan Confirmed New Coronavirus Pneumonia, and Another Suspected"},{"title3":"Asymptomatic Middle East Respiratory Syndrome Coronavirus (MERS-CoV) infection: Extent and implications for infection control: A systematic review"},{"title3":"MERS, SARS, and Ebola: The Role of Super-Spreaders in Infectious Disease"},{"title3":"Analysis of intrapatient heterogeneity uncovers the microevolution of Middle East respiratory syndrome coronavirus"}]},{"title2":"Early transmission dynamics in Wuhan, China, of novel coronavirus-infected pneumonia","References":[{"title3":"The 2019-nCoV Outbreak Joint Field Epidemiology Investigation Team, Li Q. Notes from the field: an outbreak of NCIP (2019-nCoV) infection in China : Wuhan, Hubei Province, 2019-2020."},{"title3":"A novel coronavirus genome identified in a cluster of pneumonia cases : Wuhan, China 2019-2020."},{"title3":"A novel coronavirus from patients with pneumonia in China, 2019."},{"title3":"Use of national pneumonia surveillance to describe influenza A(H7N9) virus epidemiology, China, 2004-2013."},{"title3":"A novel coronavirus emerging in China : key questions for impact assessment."},{"title3":"Evidence for camel-to-human transmission of MERS coronavirus."},{"title3":"Transmission dynamics and control of severe acute respiratory syndrome."},{"title3":"Dynamically modeling SARS and other newly emerging respiratory illnesses: past, present, and future."},{"title3":"Coronavirus infections : more than just the common cold."},{"title3":"Another decade, another coronavirus."},{"title3":"SARS and MERS: recent insights into emerging coronaviruses."},{"title3":"MERS, SARS, and Ebola: the role of super-spreaders in infectious disease."},{"title3":"A familial cluster of pneumonia associated with the 2019 novel coronavirus indicating person-to-person transmission: a study of a family cluster."},{"title3":"Real-time tentative assessment of the epidemiological characteristics of novel coronavirus infections in Wuhan, China, as at January 2020."},{"title3":"How to maintain surveillance for novel influenza A H1N1 when there are too many cases to count."}]},{"title2":"A familial cluster of pneumonia associated with the 2019 novel coronavirus indicating person-to-person transmission: a study of a family cluster","References":[{"title3":"CHP closely monitors cluster of pneumonia cases on Mainland"},{"title3":"CHP provides further information on cluster of pneumonia cases in Wuhan"},{"title3":"Wuhan wet market closes amid pneumonia outbreak"},{"title3":"Viral load in patients infected with pandemic H1N1 2009 influenza A virus"},{"title3":"Saliva as a diagnostic specimen for testing respiratory virus by a point-of-care molecular assay: a diagnostic validity study"},{"title3":"Evaluation of NxTAG Respiratory pathogen panel and comparison with xTAG respiratory viral panel fast v2 and film array respiratory panel for detecting respiratory pathogens in nasopharyngeal aspirates and swine/avian-origin influenza A subtypes in culture isolates"},{"title3":"Coronavirus as a possible cause of severe acute respiratory syndrome"},{"title3":"Zika virus infection in dexamethasone-immunosuppressed mice demonstrating disseminated infection with multi-organ involvement including orchitis effectively treated by recombinant type I interferons"},{"title3":"High prevalence of four novel astrovirus genotype species identified from rodents in China"},{"title3":"Metagenomic analysis of viromes of dromedary camel fecal samples reveals large number and high diversity of circoviruses and picobirnaviruses"},{"title3":"Identification of a novel bat papillomavirus by metagenomics"},{"title3":"Metagenomic nanopore sequencing of influenza virus direct from clinical respiratory samples"},{"title3":"Severe acute respiratory syndrome (SARS) coronavirus ORF8 protein is acquired from SARS-related coronavirus from greater horseshoe bats through recombination"},{"title3":"Clinical progression and viral load in a community outbreak of coronavirus-associated SARS pneumonia: a prospective study"},{"title3":"Severe acute respiratory syndrome coronavirus as an agent of emerging and reemerging infection"},{"title3":"A patient with asymptomatic severe acute respiratory syndrome (SARS) and antigenemia from the 2003-2004 community outbreak of SARS in Guangzhou, China"},{"title3":"Viral replication in the nasopharynx is associated with diarrhea in patients with severe acute respiratory syndrome"},{"title3":"Middle East respiratory syndrome coronavirus: another zoonotic betacoronavirus causing SARS-like disease"},{"title3":"Human intestinal tract serves as an alternative infection route for Middle East respiratory syndrome coronavirus"},{"title3":"Enteric involvement of severe acute respiratory syndrome-associated coronavirus infection"},{"title3":"Viral loads in clinical specimens and SARS manifestations"},{"title3":"Respiratory tract samples, viral load, and genome fraction yield in patients with Middle East respiratory syndrome"},{"title3":"Characterization and complete genome sequence of a novel coronavirus, coronavirus HKU1, from patients with pneumonia"},{"title3":"Discovery of seven novel mammalian and avian coronaviruses in the genus deltacoronavirus supports bat coronaviruses as the gene source of alphacoronavirus and betacoronavirus and avian coronaviruses as the gene source of gammacoronavirus and deltacoronavirus"},{"title3":"Discovery of a novel coronavirus, China Rattus coronavirus HKU24, from Norway rats supports the murine origin of Betacoronavirus 1 and has implications for the ancestor of Betacoronavirus lineage A"},{"title3":"Genomic characterization and infectivity of a novel SARS-like coronavirus in Chinese bats"},{"title3":"Severe acute respiratory syndrome coronavirus-like virus in Chinese horseshoe bats"},{"title3":"Bats are natural reservoirs of SARS-like coronaviruses"},{"title3":"Antigenic cross-reactivity between severe acute respiratory syndrome-associated coronavirus and human coronaviruses 229E and OC43"}]},{"title2":"A pneumonia outbreak associated with a new coronavirus of probable bat origin","References":[]},{"title2":"Clinical features of patients infected with 2019 novel coronavirus in Wuhan, China","References":[{"title3":"A familial cluster of pneumonia associated with the 2019 novel coronavirus indicating person-to-person transmission: a study of a family cluster"},{"title3":"A familial cluster of pneumonia associated with the 2019 novel coronavirus indicating person-to-person transmission: a study of a family cluster"},{"title3":"Epidemiological and clinical characteristics of 99 cases of 2019 novel coronavirus pneumonia in Wuhan, China: adescriptivestudy"},{"title3":"Epidemiological and clinical characteristics of 99 cases of 2019 novel coronavirus pneumonia in Wuhan, China: a descriptive study"},{"title3":"First case of 2019 novel coronavirus in the United States"},{"title3":"Clinical features of patients infected with 2019 novel coronavirus in Wuhan, China"},{"title3":"Lung CT image of a confirmed case of the 2019 novel coronavirus (2019-nCoV) infected pneumonia (With differential diagnosis of the SARS)"},{"title3":"Early transmission dynamics in Wuhan, China, of novel coronavirus-infected pneumonia"},{"title3":"Role of neutrophil to lymphocyte and monocyte to lymphocyte ratios in the diagnosis of bacterial infection in patients with fever"},{"title3":"Coronavirus infections-more than just the common cold"},{"title3":"The association between the neutrophil-to-lymphocyte ratio and mortality in critical illness: an observational cohort study"},{"title3":"A new coronavirus associated with human respiratory disease in China"},{"title3":"Monocyte/lymphocyte ratio as a better predictor of cardiovascular and all-cause mortality in hemodialysis patients: a prospective cohort study"},{"title3":"Ratio of neutrophil to lymphocyte counts-rapid and simple parameter of systemic inflammation and stress in critically ill"},{"title3":"Neutrophil-lymphocyte ratio as an early new marker in AIV-H7N9-infected patients: a retrospective study"}]},{"title2":"Clinical characteristics of 138 hospitalized patients with 2019 novel coronavirus-infected pneumonia in Wuhan, China","References":[]},{"title2":"New coronavirus pneumonia prevention and control program (6th ed) (in Chinese). 2020. http://www.nhc.gov.cn/yzygj/s7653p/202002/8334a8326dd94d329df351d7da8aefc2/files/b218cfeb1bc54639af227f922bf6b817.pdf.","References":[]},{"title2":"World Health Organization. Clinical management of severe acute respiratory infection when Novel coronavirus (nCoV) infection is suspected: interim guidance. 2020. https://www.who.int/publications-detail/clinical-management-of-severe-acute-respiratory-infection-when-novel-coronavirus-(ncov)-infection-is-suspected.","References":[]},{"title2":"KDIGO clinical practice guidelines for acute kidney injury","References":[]},{"title2":"NT-proBNP testing for diagnosis and short-term prognosis in acute destabilized heart failure: an international pooled analysis of 1256 patients: the International Collaborative of NT-proBNP Study","References":[]},{"title2":"Characteristics of and Important Lessons From the Coronavirus Disease 2019 (COVID-19) Outbreak in China: Summary of a Report of 72 314 Cases From the Chinese Center for Disease Control and Prevention","References":[]},{"title2":"World Health Organization. Summary of probable SARS cases with onset of illness from 1 November 2002 to 31 July 2003. 2003. https://www.who.int/csr/sars/country/table2004_04_21/en/.","References":[]},{"title2":"World Health Organization. Middle East respiratory syndrome coronavirus (MERS-CoV). 2019. https://www.who.int/emergencies/mers-cov/en/.","References":[]},{"title2":"Epidemiological and clinical characteristics of 99 cases of 2019 novel coronavirus pneumonia in Wuhan, China: a descriptive study","References":[{"title3":"Outbreak of pneumonia of unknown etiology in Wuhan China: the mystery and the miracle"},{"title3":"The continuing 2019-nCoV epidemic threat of novel coronaviruses to global health - the latest 2019 novel coronavirus outbreak in Wuhan, China"},{"title3":"Clinical features of patients infected with 2019 novel coronavirus in Wuhan, China"},{"title3":"Clinical management of severe acute respiratory infection when Novel coronavirus (nCoV) infection is suspected: interim guidance"},{"title3":"MERS, SARS and other coronaviruses as causes of pneumonia"},{"title3":"Identification of a novel coronavirus in patients with severe acute respiratory syndrome"},{"title3":"Isolation of a novel coronavirus from a man with pneumonia in Saudi Arabia"},{"title3":"Clinical features predicting mortality risk in patients with viral pneumonia: the MuLBSTA score"},{"title3":"Discovery of a rich gene pool of bat SARS-related coronaviruses provides new insights into the origin of SARS coronavirus"},{"title3":"Cross-host evolution of severe acute respiratory syndrome coronavirus in palm civet and human"},{"title3":"Middle East respiratory syndrome coronavirus in dromedary camels: an outbreak investigation"},{"title3":"Evidence for camel-to-human transmission of MERS coronavirus"},{"title3":"Surveillance of bat coronaviruses in Kenya identifies relatives of human coronaviruses NL63 and 229E and their recombination history"},{"title3":"Origin and evolution of pathogenic coronaviruses"},{"title3":"Fatal swine acute diarrhoea syndrome caused by an HKU2-related coronavirus of bat origin"},{"title3":"Evolution of the novel coronavirus from the ongoing Wuhan outbreak and modeling of its spike protein for the risk of human transmission"},{"title3":"Wuhan coronavirus has strong ability to infect humans. Press release"},{"title3":"From SARS to MERS, thrusting coronaviruses into the spotlight"},{"title3":"Prevalence of comorbidities in the Middle East respiratory syndrome coronavirus (MERS-CoV): a systematic review and meta-analysis"},{"title3":"Sex-based differences in susceptibility to severe acute respiratory syndrome coronavirus infection"},{"title3":"Sexual dimorphism in innate immunity"},{"title3":"Pathophysiology and burden of infection in patients with diabetes mellitus and peripheral vascular disease: focus on skin and soft-tissue infections"},{"title3":"Clinical findings in 111 cases of influenza A (H7N9) virus infection"},{"title3":"Clinical features of three avian influenza H7N9 virus-infected patients in Shanghai"},{"title3":"T-cell immunity of SARS-CoV: implications for vaccine development against MERS-CoV"}]},{"title2":"[The epidemiological characteristics of an outbreak of 2019 novel coronavirus diseases (COVID-19) in China]","References":[{"title3":"The continuing 2019-nCoV epidemic threat of novel coronaviruses to global health - the latest 2019 novel coronavirus outbreak in Wuhan, China"}]},{"title2":"Clinical findings in a group of patients infected with the 2019 novel coronavirus (SARS-Cov-2) outside of Wuhan, China: retrospective case series [correction in: BMJ 2020;368:m792]","References":[]},{"title2":"Pathological findings of COVID-19 associated with acute respiratory distress syndrome","References":[{"title3":"A new coronavirus associated with human respiratory disease in China"},{"title3":"Clinical features of patients infected with 2019 novel coronavirus in Wuhan, China"},{"title3":"A familial cluster of pneumonia associated with the 2019 novel coronavirus indicating person-to-person transmission: a study of a family cluster"},{"title3":"The clinical pathology of severe acute respiratory syndrome (SARS): a report from China"},{"title3":"Clinicopathologic, immunohistochemical, and ultrastructural findings of a fatal case of Middle East respiratory syndrome coronavirus infection in the United Arab Emirates, April 2014"}]},{"title2":"Can we contain the COVID-19 outbreak with the same measures as for SARS?","References":[{"title3":"Genomic characterization of the 2019 novel human-pathogenic coronavirus isolated from a patient with atypical pneumonia after visiting Wuhan"},{"title3":"ACE2 receptor expression and severe acute respiratory syndrome coronavirus infection depend on differentiation of human airway epithelia"},{"title3":"A novel coronavirus from patients with pneumonia in China, 2019"},{"title3":"Early transmission dynamics in Wuhan, China, of novel coronavirus-infected pneumonia"},{"title3":"Transmission dynamics and control of severe acute respiratory syndrome"},{"title3":"Clinical features of patients infected with 2019 novel coronavirus in Wuhan, China"},{"title3":"Epidemiological and clinical characteristics of 99 cases of 2019 novel coronavirus pneumonia in Wuhan, China: a descriptive study"},{"title3":"First case of 2019 novel coronavirus in the United States"},{"title3":"Time course of lung changes on chest CT during recovery from 2019 novel coronavirus (COVID-19) pneumonia"},{"title3":"Isolation, quarantine, social distancing and community containment: pivotal role for old-style public health measures in the novel coronavirus (2019-nCoV) outbreak"},{"title3":"Battling 21st-century scourges with a 14th-century toolbox"},{"title3":"Viral shedding patterns of coronavirus in patients with probable severe acute respiratory syndrome"},{"title3":"Predicting super spreading events during the 2003 severe acute respiratory syndrome epidemics in Hong Kong and Singapore"},{"title3":"Modelling strategies for controlling SARS outbreaks"},{"title3":"Household transmission of SARS, 2003"},{"title3":"Epidemiology and control of SARS in Singapore"},{"title3":"Hospitalized patients with bacterial infections: a potential focus of SARS transmission during an outbreak"},{"title3":"Public health and ethical considerations in planning for quarantine"},{"title3":"Public health measures to control the spread of the severe acute respiratory syndrome during the outbreak in Toronto"},{"title3":"SARS: public health measures in Hong Kong"},{"title3":"Controlling SARS: a review on China's response compared with other SARS-affected countries"},{"title3":"The impact of public health control measures during the SARS epidemic in mainland China"},{"title3":"A tale of two cities: community psychobehavioral surveillance and related impact on outbreak control in Hong Kong and Singapore during the severe acute respiratory syndrome epidemic"},{"title3":"The epidemiology of severe acute respiratory syndrome in the 2003 Hong Kong epidemic: an analysis of all 1755 patients"},{"title3":"SARS in healthcare facilities, Toronto and Taiwan"},{"title3":"SARS in Singapore:key lessons from an epidemic"},{"title3":"Experience of severe acute respiratory syndrome in Singapore: importation of cases, and defense strategies at the airport"},{"title3":"The severe acute respiratory syndrome: impact on travel and tourism"},{"title3":"SARS to novel coronavirus:old lessons and new lessons"},{"title3":"A novel coronavirus outbreak of global health concern"},{"title3":"China's response to a novel coronavirus stands in stark contrast to the 2002 SARS outbreak response"},{"title3":"Travelers give wings to novel coronavirus (2019-nCoV)"},{"title3":"Potential for global spread of a novel coronavirus from China"},{"title3":"Pneumonia of unknown etiology in Wuhan, China: potential for international spread via commercial air travel"},{"title3":"Asymptomatic SARS coronavirus infection among healthcare workers, Singapore"},{"title3":"Transmission of 2019-nCoV infection from an asymptomatic contact in Germany"},{"title3":"Importation and human-to-human transmission of a novel coronavirus in Vietnam"},{"title3":"Effectiveness of airport screening at detecting travellers infected with novel coronavirus (2019-nCoV)"},{"title3":"The reproductive number of COVID-19 is higher compared to SARS coronavirus"},{"title3":"COVID-19 outbreak on the Diamond Princess cruise ship: estimating the epidemic potential and effectiveness of public health countermeasures"},{"title3":"The Epidemiological Characteristics of an Outbreak of 2019 Novel Coronavirus Diseases (COVID-19):China, 2020. China CDC Weekly 2020"}]},{"title2":"Clinical and laboratory features of severe acute respiratory syndrome vis-a-vis onset of fever","References":[{"title3":"A novel coronavirus associated with severe acute respiratory syndrome"},{"title3":"Coronavirus as a possible cause of severe acute respiratory syndrome"},{"title3":"Comparative full-length genome sequence analysis of 14 SARS coronavirus isolates and common mutations associated with putative origins of infection"},{"title3":"Identification of a novel coronavirus in patients with severe acute respiratory syndrome"},{"title3":"SARS coronavirus sequencing"},{"title3":"Newly discovered coronavirus as the primary cause of severe acute respiratory syndrome"},{"title3":"A major outbreak of severe acute respiratory syndrome in Hong Kong"},{"title3":"Identification of severe acute respiratory syndrome in Canada"},{"title3":"Epidemiological determinants of spread of causal agent of severe acute respiratory syndrome in Hong Kong"},{"title3":"Case definitions for surveillance of severe acute respiratory syndrome (SARS): revised 1 May 2003"},{"title3":"Pneumonia due to viral and atypical organisms and their sequelae"},{"title3":"Pneumonia: high-resolution CT findings in 114 patients"},{"title3":"Imaging of pneumonia: trends and algorithms"},{"title3":"Aetiology of community-acquired pneumonia: a prospective study among adults requiring admission to hospital"},{"title3":"Differentiation of bacterial and viral pneumonia in children"},{"title3":"Hospital infection control guidance for severe acute respiratory syndrome (SARS): revised 24 April 2003"},{"title3":"Personal view of SARS: confusing definition, confusing diagnoses"},{"title3":"The immediate psychological and occupational impact of the 2003 SARS outbreak in teaching hospital"},{"title3":"Development of a standard treatment protocol for severe acute respiratory syndrome"},{"title3":"Severe acute respiratory syndrome: radiographic appearances and pattern of progression in 138 patients"},{"title3":"Cluster of severe acute respiratory syndrome cases among protected health-care workers: Toronto, Canada, April 2003"},{"title3":"Interim domestic guidance for management of exposures to severe acute respiratory syndrome (SARS) for health-care settings"},{"title3":"Clinical course and management of SARS in health care workers in Toronto: a case series"},{"title3":"Identification and containment of an outbreak of SARS in a community hospital"},{"title3":"Investigation of a nosocomial outbreak of severe acute respiratory syndrome (SARS) in Toronto, Canada"},{"title3":"Clinical progression and viral load in a community outbreak of coronavirus-associated SARS pneumonia: a prospective study"},{"title3":"Clinical presentations and outcome of severe acute respiratory syndrome in children"},{"title3":"Clinical features and short-term outcomes of 144 patients with SARS in the greater Toronto area"},{"title3":"An outbreak of coronavirus OC43 respiratory infection in Normandy, France"},{"title3":"Severe acute respiratory syndrome: clinical outcome and prognostic correlates"}]}]}]}